7 2 月, 2023

Mitsubishi Heavy Industries Achieves YoY Increases in Order Intake, Revenue, Business Profit, and Net Income in Third Quarter

TOKYO, Feb 7, 2023 - (JCN Newswire via SEAPRWire.com) - Mitsubishi Heavy Industries (TSE Code: 7011) announced that order intake rose 19.0% year-over-year to YEN2,966.1 billion in the third quarter ended December 31, 2022. Revenue rose 11.1% to YEN2,938.0 billion year-over-year, resulting in business profit of YEN105.2 billion, a 30.3% increase from the previous fiscal year, which represents a profit margin of 3.6%. Net income was YEN66.4 billion, an increase of 32.8% year-over-year, with a profit margin of 2.3%. EBITDA was YEN208.6 billion, a 16.4% increase from FY2021, with a profit margin of 7.1%, up 0.3 percentage points year-over-year.Other highlights included orders and revenue growth in Nuclear Power, Aero Engines, HVAC, and Commercial Aviation. YoY improvements in profitability were mainly seen in Energy Systems and Aircraft, Defense & Space resulting from revenue growth in Nuclear Power and Aero Engines as well as foreign exchange effects combined with fixed cost reductions in Commercial Aviation.　FY2022 Guidance:MHI revised its guidance for the period ending March 31, 2023, with company-wide totals unchanged from the most recent revision made on November 1, 2022, while updating business profit in Energy Systems and Aircraft, Defense & Space.CFO Message:"MHI have had a stable first three quarters this fiscal year," Hisato Kozawa, CFO of MHI commented. "We saw increases in orders and revenue in three out of four reporting segments arising from business expansion and benefits from the depreciation of the yen. Performance was especially strong in GTCC, Nuclear Power, Logistics Systems, and HVAC." Kozawa continued, "That said, we still have our work cut out for ourselves in the fourth quarter as we work to offset profitability issues caused by a variety of factors such as global inflation using all of the tools available to us. Our goal for this fiscal year is to set the stage for a successful FY2023, during which we aim to achieve the targets laid out in our 2021 Medium-Term Business Plan."About MHI GroupMitsubishi Heavy Industries (MHI) Group is one of the world?s leading industrial groups, spanning energy, smart infrastructure, industrial machinery, aerospace and defense. MHI Group combines cutting-edge technology with deep experience to deliver innovative, integrated solutions that help to realize a carbon neutral world, improve the quality of life and ensure a safer world. For more information, please visit www.mhi.com or follow our insights and stories on spectra.mhi.com.For more information, visit www.mhi.com/news/23020701.html. Copyright 2023 JCN Newswire. All rights reserved. (via SEAPRWire)

17 1 月, 2023

MX Hub (UAE) Announces Award Recipients

MX Hub, the revolutionary convergent tech accelerator inspired by SoftBank's strategy of consolidation of leaders in the Healthtech, PropTech, AI, and sharing economy sectors, has seen impressive progress in just two months since its creation.One of the major achievements of MX Hub is the consolidation of assets into the Metabook Sharing Economy platform, which aims to do revenue sharing with agents in tens of countries, promoting the innovations of MX100 startups. This strategy is a key component in building a global Revenue Sharing Digital Economy, led by top influencers and powered by the most appealing innovations.In the last month, MX Hub residents from MX100 have received multiple awards. The founders of BloxBytes and Vaival technologies were recognized at different events in December, with CEO, Anjum Shahzad, being awarded PASHA ICT Award , Asia Pacific ICT Award ( among other 16 countries) and an award from the President of Pakistan in person as an appreciation for great contribution in Web3.0 development space.The top success story is, Bloxbytes has listed in top 100 metaverse innovatorsby the metaverse spectrum and Vaival Technologies have received yet another prestigious leadership award, further solidifying the effectiveness of MX Hub's accelerator program.MX Edtech Rating, the only rating of its kind with proven results, is also a key component of MX Hub's success. The MX 100 Rating event, which was postponed for March to include global leaders in emerging technologies, is based on factors such as team leadership in tech and business, scalability of startups, presence in international markets, and commercialization of products. The final stage of the rating process includes voting from an expert panel of global top experts, such as Adiv Baruch, Dr. Robert Goldman, and fintech influencer Brett King.MX Hub's mission is to accelerate the growth for top-rated startups, and with their impressive achievements in such a short period, it's clear that they are on the right track.About MX HubMX Hub is a Dubai (UAE) based global gateway for emerging startups and post- revenue companies that provides tailored one-stop acceleration solutions. It is a first-of-its-kind phygital platform that offers a unique physical space that is supported by a virtual twin version with multifunctional options, VIP meeting spaces and chat rooms. www.mxhub.me Copyright 2023 ACN Newswire. All rights reserved. (via SEAPRWire)

30 11 月, 2022

Yew Lee Posts RM6.1 Million Revenue in 3Q

KUALA LUMPUR, Nov 30, 2022 - (ACN Newswire via SEAPRWire.com) - Yew Lee Pacific Group Berhad, a manufacturer of industrial brushes as well as trading of industrial hardware and machinery parts, today announced that the Group recorded revenue of RM6.10 million for the third quarter ended 30 September 2022 (3Q FY2022).Managing Director of Yew Lee, Mr. Ang Lee LeongThere are no comparisons on a year-over-year basis as the Group was listed on the ACE Market of Bursa Malaysia Securities Berhad on 7 June 2022.For the quarter under review, Yew Lee reported gross profit of RM2.12 million while registering profit before tax (PBT) of RM0.96 million and profit after tax of RM0.76 million. For the nine-month period ended 30 September 2022 (9M 2022), the Group registered RM24.35 million in revenue while recording a profit before tax of RM0.39 million and a loss after tax of RM0.41 million.Manufacturing activities contributed RM3.84 million to total revenue while trading activities contributed RM2.27 million in 3Q FY2022.Managing Director of Yew Lee, Mr. Ang Lee Leong said, "We continue to sustain and generate profit from our operations. It is worth noting that stripping the one-off listing expenses of RM2.70 million, the Group would have reported a 9M 2022 PBT of RM3.0 million."The Group's immediate plans is to reduce its dependency on the rubber glove industry by seeking opportunities in the semiconductor, timber, glass and agriculture industries. We are encouraged by the political stability from the appointment of a new Prime Minister, and we hope that the new government will be supportive of the economy with sound policies and measures.""Besides diversifying our customer base, which will take time, the Group is also improving its manufacturing efficiency and automating manufacturing processes by acquiring additional automated machinery and equipment to support the long-term growth of the business. We are also expanding the trading of industrial hardware and machinery parts especially in the central and southern regions of Peninsular Malaysia and, expanding to more markets overseas."The Group's overseas markets include Thailand, Vietnam, Indonesia and Taiwan, which contributed about a quarter to total revenue in the financial year ended 31 December 2021.Yew Lee Pacific Group Bhd: 0248 [BURSA: YEWLEE], https://yewlee.com.my/ Copyright 2022 ACN Newswire. All rights reserved. (via SEAPRWire)

24 11 月, 2022

Minetech Records 32% Increase in Revenue for 2Q

KUALA LUMPUR, Nov 24, 2022 - (ACN Newswire via SEAPRWire.com) - Civil engineering specialist and bituminous products manufacturer Minetech Resources Berhad today reported that the Company recorded a 31.9% rise in revenue to RM26.9 million for the second quarter ended 30 September 2022 (2Q FY2023) compared with RM20.4 million in the corresponding quarter of the last financial year (2Q FY2022).Matt Chin, Executive Director of MinetechThe Company registered a loss before tax (LBT) of RM1.5 million for the quarter under review compared with LBT of RM4.7 million in 2Q FY2022.On a segmental basis, the civil engineering division recorded a 8.1% rise in revenue to RM16.1 million in 2Q FY2023 compared with RM14.9 million in 2Q FY2022. The manufacturing division, which produces bituminous products for pipe coating, waterproofing and sealing, posted a 166.7% increase in revenue to RM7.2 million compared with RM2.7 million in the same quarter of the previous financial year.For the first-half of the financial year ended 30 September 2023 (1H FY2023), Minetech registered a 36.9% increase in revenue to RM50.9 million compared with RM37.2 million in 1H FY2022. The Company recorded LBT of RM3.1 million in the period under review compared with RM9.1 million in 1H FY2022.Matt Chin, Executive Director of Minetech, said, "We continue to see our financial performance improve with narrower losses on higher revenue contribution from the civil engineering division's Selinsing Gold Mine due to increase in work volume as well as from the Cheras-Kajang Highway, Wangsa Brezza Hill and GM Emerald Square.""We have seen a significant increase in revenue contribution from the manufacturing division mainly due to the rise in sales of coating enamel and blown asphalt products as a result of improved demand from both domestic and overseas markets.""While economic growth is on a stronger footing based on Malaysia's third-quarter GDP figures, we note the increased risks of a slowdown in 2023 as global uncertainties stemming from the Russia-Ukraine conflict, China's slowdown and inflationary pressure continue to weigh on sentiments. We continue to emphasise various cost-control measures and cash conservation and at the same time exploring opportunities that have seen us venturing into technology and innovation and penetrating into second-tier construction activities. These initiatives have helped us weather the storm and continue to create value for shareholders and other stakeholders."Minetech Resources Berhad: 7219 [BURSA: MINE], https://minetech.com.my/ Copyright 2022 ACN Newswire. All rights reserved. (via SEAPRWire)

24 11 月, 2022

EC Healthcare Announces FY2022/23 Interim Results, Revenue Increased 31.1% YoY Mainly Driven by Medical Services

HONG KONG, Nov 24, 2022 - (ACN Newswire via SEAPRWire.com) - EC Healthcare (the "Company", which together with its subsidiaries is referred to as the "Group", SEHK stock code: 2138), the largest non-hospital medical group in Hong Kong, announces today its unaudited interim results for the six months ended 30 September 2022 (the "Period").Business Highlight -- Total revenue increased by 31.1% YoY to HK$1,893.2 million-- Revenue from medical services segment rose by 47.5% YoY to HK$1,174.8 million, boosting its revenue contribution to 62.1%-- Revenue from aesthetic medical and beauty and wellness services segment decreased by 2.0% YoY to HK$607.4 million, accounted for approximately 32.1% of total revenue-- Driven by previous acquired veterinary business, revenue from other services increased by 301.9% YoY to HK$111.0 million, represents 5.8% of the total revenue-- Organic revenue(1) increased by 22.8% YoY to HK$1,773.7 million, accounting for 93.7% of the total-- EBITDA during the period was HK$269.9 million-- Net profit after tax for during the period was HK$105.2 million-- Basic earnings per share during the period amounted to 6.8 HK cents-- The Board declared an interim dividend of 5.8 HK cents per Share, representing a payout ratio of 85.3%, which will be payable in cash-- As at 30 September 2022, the total valuation of the Group's M&A transactions executed was HK$219.3 million, spanning medical specialty services, veterinary and health screening services, which further strengthened the Group's medical services layout.-- The Group's suite of medical services spans 35 specialties and disciplines, and the number of full-time and exclusive registered practitioners has increased to 293-- The Group has maintained premium service quality with 99.98%(6) of customers' satisfaction rate-- The contribution from existing customers accounted for 71.6%(3,7) to the Group's total revenue. -- Customer loyalty remained high with repurchase purchase rate of 93.7%(4,7).-- Total number of service points increased to 154, total gross floor area ("GFA") increased by 24.1% YoY to approximately 557,000 sq. ftDuring the Period, the Group stayed resilient in the face of multiple challenges, including global economic downturn, absence of medical tourism amidst prolonged travel restrictions, weak local retail sentiment and business disruptions caused by the fluctuation of COVID-19. Thanks to robust demand on the Group's medical services and its diversified business strategy, the Group was still able to increase its medical market share, diversifying its scope of services, and bolstering its leading position in the healthcare sector as Hong Kong's largest non-hospital medical service provider. The demand for medical services provided by the Group remains strong, and the Group able to increase its market share during the period. During the Reporting Period, sales volume increased by 18.3% year-on-year ("YoY") to HK$1,812.4 million. Revenue increased by 31.1% YoY to HK$1,893.2 million. Organic revenue(1) of the Group increased by 22.8% YoY to HK$1,773.7 million, accounting for 93.7% of the total driven by effective sales strategy. The total valuation of the Group's M&A transaction executed during the Period was HK$219.3 million, spanning medical specialty services, veterinary and health screening services, further strengthening the Group's client-centric services layout. Nevertheless, the Group's net profit after tax for during the period decreased by 46.3% YoY to HK$105.2 million. Net profit margin was under pressure and decreased by 8.0 percentage point to 5.6% due to the Compulsory Closure of the Group's beauty and wellness businesses in Hong Kong and Macau as well as business disruption in Mainland China from COVID-19. Increasingly fierce competitive landscape, rising cost structure from inflation, temporary low operation leverage of the newly established service points from previous financial year and increase depreciation and amortization expenses incurred from the newly acquired medical assets undermined the Group's profitability during the Period. In addition, the capital expenditures expended on organic expansions of our new medical facilities are yet to commence services to generate income within the period. As a result, the net profit attributable to equity shareholders of the Company was HK$80.0 million. Basic earnings per share was 6.8 HK cents, compared to 14.2 HK cents for the same period last year.With excellent customer service provided by the professional teams, the Group had built a loyal customer base through our enclosed ecosystem over the years. During the Period, the number of unique customers steadily increased to 122,883(2,7) and the contribution from existing customers accounted for 71.6%(3,7) to the Group's total revenue. Customer loyalty remained high with repurchase purchase rate of 93.7%(4,7). Driven by the synergies created by the Group's enclosed healthcare ecosystem, over 28.1%(5) of its customers had made purchases across its various brands in the Period. Meanwhile, the Group maintained premium service quality with 99.98%(6) of customers' satisfaction rate. The number of service points increased through organic expansion and acquisitions. As at 30 September 2022, the Group had a total number of 154 service points comprising 134 in Hong Kong, 4 in Macau and 16 in Mainland China with the total aggregate GFA increased by 24.1% YoY to approximately 557,000 sq. ft. Out of the net increase of approximately 108,000 sq. ft. compared to first half of FY22, approximately 69.1% came from medical business and approximately 22.8% came from aesthetic medical and beauty and wellness services business respectively. The Group's suite of medical services spans 35 specialties and disciplines, and the headcount of full-time and exclusive registered practitioners has increased to 293.Strong growth in medical segmentMedical segment being the essential needs and continued to be the key growth driver. The Group continued to gain market share in the healthcare services industry through both organic expansion and M&A growth. Revenue from the Group's medical services segment rose by 47.5% YoY to HK$1,174.8 million, boosting its revenue contribution to 62.1%, of which organic expansion and M&A completed during first half of FY23 accounted for approximately 90.8% and 9.2% respectively. Organic growth was driven by surged demand, effective sales strategy and rising healthcare sentiment. During the Period, the total valuation of acquisitions executed in medical segment was HK$175.1 million. Mild decline in aesthetic medical & beauty and wellness services segmentDuring the Period, revenue contributed by aesthetic medical and beauty and wellness services decreased by 2.0% YoY to HK$607.4 million, accounted for approximately 32.1% of total revenue. Revenue from Hong Kong recorded a mile decline of 5.4% YoY to HK$460.7 million due to 20 days of Compulsory Closure in April 2022 and followed by a gradual recovery from pent-up demand. Mainland aesthetics market facing business disruption caused by COVID. During the Period, revenue from Mainland China increased by 12.6% YoY to HK$89.8 million despite an average of 26 days, 10 days and 122 days of business disruption in Shenzhen, Guangzhou and Shanghai, respectively. Revenue from Macau increased marginally 7.7% YoY to HK$56.8 million due to an average of 31 days of Compulsory Closure.Booming growth in others segmentDuring the Period, revenue from other services increased by 301.9% YoY to HK$111.0 million, representing 5.8% of the total revenue, primarily attributable to the M&A expansion into the veterinary sector. Mr. Eddy Tang, Chairman, Executive Director and Chief Executive Officer of EC Healthcare said, "While Hong Kong local consumption gradually recovers, benefitting from the Hong Kong Government's pandemic policy stance towards "Normalization" with lifting off quarantine for inbound travelers, the recessionary market backdrop could still pose headwinds to our businesses. Yet, we believe that the medical market remains lucrative and public-private partnership will continue to increase Hong Kong's private medical spending in the long run. As part of our accretive acquisition strategy, we will continue to diversify within the medical and beauty sectors with acquired brands that are complementary and add value to our core business in order to build a one-stop healthcare and wellness platform to expand customer's lifetime value. We will also expand the strategic partnerships with key players in technology, telecom, insurance, property, and pharmaceutical industries to form our healthcare ecosystem. We have been striving to improve our operational excellence by enhancing corporate structure and management capability, optimizing our resources with priorities through digital transformation. The Group will continue to enhance its talent's productivity and loyalty through the unique "Co-Owner" and "Servant Leadership" company culture."About EC Healthcare EC Healthcare is Hong Kong's largest non-hospital medical service provider*, leveraging its core businesses of preventive and precision medicine, and committed to developing medical artificial intelligence by integrating its multi-disciplinary medical services. The move, which is supported by the Group's high-end branding and quality customer services, is aimed at offering customers safe and effective healthcare and medical services with professionalism. The Group is a constituent stock of the Hang Seng Composite Index and the MSCI Hong Kong Small Cap Index.The Group principally engages in the provision of one-stop medical and health care services in Greater China. The Group provides a full range of services and products under its well-known brands, including those of its one-stop aesthetic medical solutions provider DR REBORN which has ranked first in Hong Kong by sales for years, a professional hair care center HAIR FOREST, primary care clinics jointly established with health management centre re:HEALTH, a vaccine centre Hong Kong Professional Vaccine HKPV, General outpatient clinic Tencent Doctorwork, the largest one-stop pain management centre in Hong Kong New York Medical Group, the comprehensive dental centres Bayley & Jackson Dental Surgeons, EC DENTAL CARE and Health and Care Dental Clinic, an advanced diagnostic and imaging centre HKAI, an oncology treatment centre reVIVE, a day procedure centre HKMED, a specialty clinic PREMIER MEDICAL CENTRE, SPECIALISTS CENTRAL and NEW MEDICAL CENTER, a paediatric centre PRIME CARE, a gynaecology specialist ZENITH MEDICAL CENTER AND PRENATAL DIAGNOSIS CENTRE, PathLab Medical Laboratories, Ophthalmology Center VIVID EYE and EC Veterinary Hospital and Imaging Center.*According to independent research conducted by Frost and Sullivan in terms of revenue in 2020 and 2021Note:1 Total revenue minus revenue recognized from the newly acquired assets during period. 2. Based on revenue for the year.3. Revenue contribution by existing customers to the total revenue for the period4. Annualise revenue from old customers during the reporting period, divided by FY22 total revenue.5. Number of customers who purchased services from more than one brand for the period divided by total number of customers for the period. Based on data from internal system, include data from 31 brands6. 100% minus the percentage of material unfavorable feedback of total revenue for the period7. Based on data from internal system, include data from 39 brands For further information, please contact: iPR Ogilvy Limited Callis Lau / Lorraine Luk / Tim Tin Tel: (852) 2136 6952 / 2169 0467 / 3920 7654 Fax: (852) 3170 6606 Email: ech@iprogilvy.com Copyright 2022 ACN Newswire. All rights reserved. (via SEAPRWire)

31 8 月, 2022

Huisen Household Announces 2022 Interim Results

HONG KONG, Aug 31, 2022 - (ACN Newswire via SEAPRWire.com) - China's major furniture product manufacturer Huisen Household International Group Ltd. ("Huisen Household" or "the Group"; stock code: 2127.HK) announced unaudited interim results for the period ended 30 June 2022 ("the Reporting Period") yesterday. During the reporting period, the weak real estate market and the interest rate hike caused a contraction in the number of deals made. Inflation caused by the quantitative easing policy started to emerge during 2022, fuelling the uncertainties of economy. Reduction in subsidy, the U.S. housing price remained at a high level, and the rise in interest rate have all contributed to the plunge in the number of property transaction, leading to a relatively weak demand for furniture in the first half of 2022.In the first half of 2022, The Group's revenue was approximately RMB1.96 billion, representing a decrease of approximately 18.3% from approximately RMB2.40 billion compare to the same period of 2021. Profit was approximately RMB298.0 million, representing a decrease of approximately 29.2% from approximately RMB420.8 million compare to the same period of 2021.Mr. Zengming, chairman and executive director, said: "The weakened real estate markets in Europe and U.S. and a relatively faint furniture market have led to the decrease in the number of orders from the major customers of the Group. Notwithstanding the drop in revenue during the reporting period, the Group has successfully expanded its business to certain small and medium size enterprises customers and products were sold to more different countries or regions gradually. During the reporting period, we have reached an agreement of cooperation with Home-depot, a well-known chain store of furniture in U.S., orders from Home-depot have been increased progressively." Panel-type FurnitureDuring the reporting period, the decrease in demand from the overseas market such as the U.S. led to a decrease in revenue of panel-type furniture from approximately RMB2.26 billion to approximately RMB1.85 billion for the reporting Period, representing a decrease of 17.9%. The decrease in gross profit margin was mainly attributable to (i) the reduction in average selling price for some of the panel-type furniture as a result of the depreciation of RMB against U.S. dollar and (ii) the increase in the price of raw materials.Upholstered FurnitureDuring the reporting period, the revenue from upholstered furniture recorded a decrease of approximately 28.1%. The decrease in revenue was mainly due to the decrease in demand for upholstered furniture as a result of the slowdown of the the real estate market in Europe and U.S. During the Reporting Period, the average selling price for some of the upholstered furniture has been reduced as a result of the depreciation of RMB against U.S. dollar, leading to an overall decrease in the gross profit margin of the upholstered furniture.Sport-type FurnitureDuring the reporting period, the revenue from sport-type furniture amounted to RMB53.9 million, representing a decrease of 22.8% from the corresponding period of 2021, mainly due to the decrease in order during the Reporting Period. The gross profit margin of sport-type furniture decreased from 30.1% in the corresponding period of 2021 to 26.6% in the Reporting Period, mainly due to the reduction in the selling price of some of the products. Looking to the second half of 2021, During the reporting period, the Group continued to strengthen its original design capability and launch more original design manufacturing ("ODM") products. Revenue of ODM furniture accounted for more 81.1% of the Group's total sales for the Reporting Period, and the proportion maintained at above 80%. Original Equipment Manufacturing ("OEM") Furniture accounted for 18.9%.On 6 January 2022, the Group entered into an agreement with the local government authority to obtain the right to use two parcels of land with a total area of 33,539.30 sq.m. and on 24th August 2022 obtain the right to use another two parcels of land with 65,556.80 sq.m. in Nankang District, Ganzhou. Those four lands are nearby with total area 99,096.10 sq.m. are mainly for the construction of a new plant which will specialise in the manufacturing of particleboard, a major material used in the production of furniture products. The new plant is close to the factory operated by Ganzhou Aigesen Wood Panel Co., Ltd*.For improving and optimizing the marketing and advertising campaign of the Group and to better promote the smart furniture products of the Group, the Group has entered into a strategic cooperation agreement with Netjoy Holdings Limited (stock code: 2131) ("Netjoy"), a company listed on the Main Board of The Stock Exchange of Hong Kong Limited (the "Stock Exchange") on 24th January 2022. The Group and Netjoy shall jointly cooperate for the development of a cloud-based virtual reality smart home project based on Metaverse, including but not limited to developing virtual reality exhibition hall for consumers' interactive experience, live broadcast sales by artificial intelligence ("AI") sales anchor and promotion and sales of the smart home products of the Group through the application of AI technologies.Looking ahead to the second half of 2022, though various countries have already relaxed the social distancing measures and travel restriction, with the energy crisis in Europe and the pressure of high inflation in the U.S., the market sentiment in the private housing market in Europe and U.S. is difficult to rebound swiftly, it is expected that the export of furniture made in China would still experience a period of depression. The "World Furniture Outlook 2022" issued by Centre for Industrial Studies (CSIL) of Italy predicts that the growth in global furniture consumption could be around 4% in 2022, and the market performance for European and Asian countries are better than that as compared to other countries. While the growth is relatively minimal, the group will continue to uphold its business strategy to continuously explore markets outside U.S., establish strong relationship with new customers, and continually strengthens the ODM capabilities, making advancement of invested projects with the raised funds in a down-to-earth manner. We will also solidify our core competitiveness, and continuously increasing our market share, thus to keep on to be the leading force while being the leader of the panel type furniture industry.About Huisen Household International Group Limited We are a manufacturer of furniture products in the PRC with a primary focus on the manufacture and sales of panel furniture by way of ODM. Over 80 % of our revenue from our furniture products was generated from our ODM business and the remaining was generated from our OEM business. All of the products we produced for sales were not under our own brands. Our vertically integrated business model allows us to combine our in-house product design and development expertise with our integrated manufacturing platform, providing full range services covering product design and development, manufacture and sales of panel furniture, and securing stable supply of our principal production materials, i.e., particleboards and steel tubes by manufacturing them on our own. Copyright 2022 ACN Newswire. All rights reserved. (via SEAPRWire)

23 8 月, 2022

Sino Biopharmaceutical (1177.HK) Announces 2022 lnterim Results, Revenue up by 5.9% to RMB15.19 billion

HONG KONG, Aug 23, 2022 - (ACN Newswire via SEAPRWire.com) - Sino Biopharmaceutical Limited ("Sino Biopharmaceutical" or the "Company", together with its subsidiaries, the "Group") (HKEX:1177), a leading innovation-driven pharmaceutical conglomerate in the PRC, has announced its unaudited Interim results for the six months ended 30 June 2022 (the "Period").Development Highlights-- The Group achieved considerable sales growth from a number of new products and oncology products, with sales of new products launched within five years accounted for approximately 43.5% of the Group's total revenue in the first half of 2022, up from approximately 36.9% for the same period last year.-- As of 30 June 2022, the Group had a total of 40 innovative drug candidates in the oncology field, 8 innovative drug candidates in the field of liver disease, 9 innovative drug candidates in the respiratory system field in development process for clinical application, and 1 innovative drug candidate in the field of surgery/analgesia in phase III clinical trial. Furthermore, the Group had a total of 23 biosimilar or generic drug candidates in the oncology field, 9 other biosimilar or generic drug candidates in the surgical/analgesic field, 5 biosimilar or generic drug candidates in the field of liver disease and 20 biosimilar or generic drug candidates in the respiratory system field in development process for clinical application.-- Focus V (Anlotinib Hydrochloride Capsules) was approved for the fifth indication-differentiated thyroid cancer in the first half of 2022. To date, Anlotinib has been approved for five indications: third-line non-small cell lung cancer, third-line small cell lung cancer, soft tissue sarcoma, medullary thyroid cancer and differentiated thyroid cancer.-- TDI01 is a highly selective inhibitor of ROCK2 and is currently in development process of phase I clinical trial for the target indications of pneumoconiosis, pulmonary fibrosis and graft versus host disease. There is no approved drug for pneumoconiosis worldwide, TDI01 is expected to fill this gap and be a boon to pneumoconiosis patients. -- SFT-1001 and SFT-1003 are two soft mist inhalation products that are currently in late clinical stage. As of 2021, there are only five soft mist inhalation products available worldwide, with a global market size of over US$3 billion and a compound growth rate of over 35% in the past five years, and the global soft mist market is expected to each US$7 billion by 2030.During the Period, the Group recorded revenue of approximately RMB15.19 billion, an increase of approximately 5.9% against last year. Profit attributable to the owners of the parent company was approximately RMB1.92 billion. Earnings per share attributable to the owners of the parent company were approximately RMB10.30 cents. Excluding the share of profits and losses of associates and a joint venture (net of related tax and non-controlling interests), certain non-cash items and one-off adjustments, adjusted non-HKFRS profit attributable to the owners of the parent was approximately RMB1.66 billion, an increase of approximately 4.5% over that in the same period last year. Sales of new products accounted for approximately 43.5% of the Group's total revenue for the period, while it was approximately 36.9% for the same period last year. The Group's liquidity remains strong, with cash and bank balances classified under current assets of approximately RMB7.77 billion, bank deposits classified under non-current assets of approximately RMB6.84 billion, and wealth management products of approximately RMB7.64 billion in aggregate, the Group's total fund reserve was approximately RMB22.25 billion at the period end.The Board of Directors has declared the payment of an interim dividend of HK6 cents per share. (2021: HK4 cents).Sales: Harvested years of R&D results, sales of new products as a percentage to revenue climbedThe Group has obtained significant benefits from years of high research and development, and continues to focus on development of related products in the areas of specialist therapeutic. During the period, the sales revenue of new products launched within five years was approximately RMB6.61 billion, accounting for approximately 43.5% of the total revenue of the Group from approximately 36.9% last year.During the Period, the Group's oncology, liver disease and cardio-cerebral vascular medicines continued to lead in sales contribution. Sales of oncology medicines increased by 16.7% year-on-year to approximately 4.96 billion, accounting for approximately 32.6% of the Group's revenue. Sales of liver disease (hepatitis) medicines and cardio-cerebral vascular medicines increased by approximately 11.1% and 13.8% year-on-year to approximately 2.01 billion and 1.55 billion, respectively, accounting for approximately 13.2% and 10.2% of the Group's revenue. In addition, the sales contributions of products in various areas such as surgery/analgesia, respiratory system and others went up hand-in-hand. Sales of surgery/analgesia and respiratory system medicines accounted for approximately 16.6% and 10.0% of the Group's revenue, respectively.In the area of oncology, since its launch in 2018, the revenue from sales of Anrotinib has continued to grow rapidly and is expected to grow at a compound rate of 46% in the period between 2018 and 2022. During the Period, sales of Annike (Penpulimab monoclonal antibody injection) increased significantly against the same period last year. F-627 (Efbemalenograstim alpha, long-acting granulocyte colony-stimulating factor) is currently under marketing application stage. It provides a safety advantage over mainstream second generation products currently on the market, is expected to be approved in China in the first half of 2023.In the area of surgery/analgesia, the Group focused on hospital access and high-potential area development, specifically on developing and increasing coverage of secondary hospitals and community healthcare facilities, driving the rapid growth of Debaian (Flurbiprofen) Cataplasms in the first half of the year.In the area of liver disease, the Group made efforts to strengthen academic promotion so as to expand doctor coverage and enhance expert recognition, as well as actively identified new patients and new market to develop, driving the rapid growth of sales revenue of Tianqing Ganmei Injection during the Period.R&D: Continued to focus on new products in specialist therapeutic areasThe Group has continued to focus R&D efforts on new oncology, surgery/analgesia, hepatitis, respiratory system and cardio-cerebral vascular medicines. As of 30 June 2022, a total of 418 pharmaceutical products had obtained clinical trial approval, or were under clinical trial or applying for production approval. Of them, 29 were for under hepatitis, 230 for oncology, 31 for respiratory system medicines, 9 for endocrine, 16 for cardio-cerebral medicines, 3 for surgery, 4 for analgesia and 96 for other medicines.Prospects: Two-pronged approach of independent research and development, focusing more on products with high innovation and market potentialIn the future, the Group will build a healthier, more diversified and sustainable revenue structure by continuing to build on traditional public hospital sales, invest more resources in new marketing channels and new marketing tools, and gradually expanding their share of revenue. In view of the potential impact of the national volume-based procurement policy on generic drugs, the Group has re-evaluated and optimised its product lines under development from the perspective of innovation and market value, focusing more on products highly innovative and with market potential.The Group will continue to invest more resources in innovative R&D facilities, personnel and projects. Innovation has become a key driver of growth for the Group, with the share of revenue from innovative medicines expected to reach 24% by 2022. Looking ahead, the Group plans to attain revenue exceeding the RMB10 billion mark from innovative medicines by 2023, further increasing the share of revenue from them in the Group's total. The Group aims to become a world-class innovative pharmaceutical group by 2030, with a revenue target of HK$100 billion, of which over 60% is expected to be contributed by innovative drugs.Looking ahead, the Group is focusing on four therapeutic areas, namely oncology, surgery/analgesia, liver disease and respiratory system, and will strive to achieve its 2030 target by adopting a two-pronged approach - pursuing independent research and development and innovation-driven business development.About Sino Biopharmaceutical Limited (HKEX:1177)Sino Biopharmaceutical Limited is a leading, innovative R&D-driven pharmaceutical conglomerate in the PRC. Its business encompasses a fully-integrated chain which covers an array of R&D platforms, a line-up of intelligent production and a strong sales system. The Group's products have gained a competitive foothold in various therapeutic categories with promising potential, comprising a variety of biopharmaceutical and chemical medicines for oncology, surgery/analgesia, hepatitis, and respiratory system.Sino Biopharmaceutical is a constituent stock of the following indices: MSCI Global Standard Indices - MSCI China Index, Hang Seng Index, Hang Seng China Enterprises Index, Hang Seng Composite Index, Hang Seng Healthcare Index, Hang Seng SCHK Mainland China Healthcare Index, Hang Seng Composite LargeCap Index, Hang Seng Composite LargeCap & MidCap Index, Hang Seng China (Hong Kong-listed) 100 Index and Hang Seng Stock Connect Hong Kong Index, etc.. Sino Biopharm was ranked as one of "Asia's Fab 50 Companies" by Forbes Asia for three consecutive years in 2016, 2017 and 2018. Copyright 2022 ACN Newswire. All rights reserved. (via SEAPRWire)

23 8 月, 2022

Kingsoft Announces 2022 Interim and Second Quarter Results

HONG KONG, Aug 23, 2022 - (ACN Newswire via SEAPRWire.com) - Kingsoft Corporation Limited ("Kingsoft" or the "Company"; HKEx stock code: 03888), a leading Chinese software and Internet service company, has announced its unaudited 2022 interim results and its second quarter results for the period ended 30 June 2022.For the first half of 2022, the revenue of Kingsoft increased 21% year-on-year to RMB3,687.2 million. Revenue from office software and services business increased 15% year-on-year to RMB1,795.7 million. Revenue from online games and others increased 28% year-on-year to RMB 1,891.5 million. Revenue from office software and services and online games and others represented 49% and 51%, respectively, of total revenue for the first half of 2022. Gross profit for the first half of 2022 increased 18% year-on-year to RMB2,970.0 million, while operating profit amounted to RMB918.2 million.For the second quarter of 2022, the Company's revenue increased 24% year-on-year to RMB1,834.2 million. Revenue from office software and services business increased 18% year-on-year to RMB924.6 million. Revenue from online games and others business increased 31% year-on-year to RMB909.6 million. Revenue from office software and services and online games and others represented 50% and 50%, respectively, of total revenue for the second quarter of 2022. Gross profit for the second quarter of 2022 increased 22% year-on-year to RMB1,467.7 million, while operating profit increased 82% year-on-year to RMB418.7 million.Mr. Jun LEI, Chairman of the Company, commented, "Despite the challenges posed by the recurrence of the pandemic, we remained focused on our strategy and achieved satisfactory results in our core businesses. Kingsoft Office Group is committed to empowering the digital transformation of institutional users while enhancing the cloud office user experience for individual users. We focus on technological empowerment, product innovation, service enhancement as well as marketing channel and eco-system expansion. Meanwhile, we continue to pursue the product strategy of 'multi-screen, cloud, content, artificial intelligence ("AI") and collaboration' and have achieved good operational performance. Regarding our online games business, we adhere to a strategy on premium games and focus on technology innovation, as well as constant cultural facets enrichment, which promote further game development."Mr. Tao ZOU, Chief Executive Officer of the Company, added, "For the second quarter of 2022, the Company's revenue increased 24% year-on-year to RMB1,834.2 million. Driven by the growth of subscription revenue from individual and institutional subscription businesses, our office software and services business increased by 18% year-on-year during the second quarter of 2022. Our online games and other business increased by 31% year-on-year during the second quarter of 2022, primarily driven by the contribution of mobile games launched in the fourth quarter of 2021 such as JX World III and JX I: Gui Lai."BUSINESS REVIEWOffice Software and ServicesDuring the quarter, the revenue of office software and services increased 18% year-on-year to RMB924.6million. Individual subscription business sustained growth momentum. Based on the continuous enhancement of cloud office experience, Kingsoft Office Group developed and introduced various new functions dedicated to specific scenarios to drive the active use of cloud services and continuous increase in subscription payment. We remained focused on attracting more long-term paying users and the number of premium subscribers continued increasing.In response to the government departments demand for digital management, end-to-cloud integration and mobile office, our products are highly compatible with government office systems, which assist the government in achieving informatization gradually and realizing centralized document management, effective and efficient file application, collaboration features, security control etc. In response to soaring demand for digital transformation among enterprises, our core products focus on solving pain points such as uploading documents to the cloud and ensuring file transfer security through continued optimization and the assistance of quality customer services.Kingsoft Office Group has closely monitored the localization industry trend. As the localization gradually penetrates into local government, we take the initiative to tap those markets. Driven by favorable policies and industry demand, our penetration in the industry localization continues to increase. In addition, demand for integrated end-to-cloud products from customers in the localization industry, such as finance, energy and telecommunications, also continues to grow. We have further optimized the re-flowable and fixed-layout document format standards of our localization products to provide an efficient and integrated user experience, which would further strengthen the competitiveness of our products.Kingsoft Office Group continued to strategically play down its advertising business by reducing the number of advertising spaces and the frequency of push notifications. Since we strived to improve the quality of clicks and reduce user interference, our advertising business was undergoing a steady and gradual decline.Online Games and OthersDuring the quarter, the revenue of online games and other business increased by 31% year-on-year to RMB909.6 million. Our flagship JX Online III PC game remained stable. Upon the launch of the non-deleting test in China at the end of last year, JX World III maintained an outstanding reputation and a high popularity among gamers. In addition, the game launched in Hong Kong, Macau and Taiwan during the quarter and achieved an excellent performance.Looking ahead to the third quarter, we launched the open beta across all platform and a new section for JX World III and will celebrate the 13th anniversary of JX Online III PC game. Through continuous content upgrade and technology innovation, we strive to sustain the vitality of our core I P. Meanwhile, we also uphold our corporate responsibility and continue to explore the social value of our games. Biphase, our initial self-developed charity game which focuses on bipolar disorder, has received multiple awards and acclamation from international gaming authorities upon its debut overseas last year. In addition, the game has also received the license approval in July this year and is scheduled for launch in China.Mr. Jun LEI concluded: "In the second quarter, we embraced the change of the complex environment and achieved further development by continuously enhancing our products and services. Looking ahead, the Group will adhere to technological empowerment, maintain our investment in R&D and enhance operational efficiency. We will keep focusing on our core strategies, adhere to integrity and innovation to empower our users and partners and create long-term returns for our shareholders."About Kingsoft Corporation LimitedKingsoft is a leading software and Internet services company based in China listed on the stock exchange of Hong Kong. It has three main subsidiaries including Kingsoft Office, Seasun and Kingsoft Shiyou. Following the implementation of its "mobile internet transformation" strategy, Kingsoft has completed the comprehensive transformation of its overall business and management models, and formed a strategic platform with office software and interactive entertainment as the pillars and cloud services and AI as the new directions. The Company has more than 7,000 staff around the world and enjoys a large market share in China. For more information, please visit http://www.kingsoft.com.Kingsoft Investor Relations:Francie Lu Tel: (86) 10 6292 7777 Email: ir@kingsoft.comFor further queries, please contact Hill+Knowlton Strategies Asia:Ovina Zhu Tel: (852) 2894 6315 Email: kingsoft@hkstrategies.com Copyright 2022 ACN Newswire. All rights reserved. (via SEAPRWire)

4 7 月, 2022

Ausnutria: Adjusted Channel Strategies in Response to Market Changes and Committed to Long-Term Development

HONG KONG, Jul 4, 2022 - (ACN Newswire via SEAPRWire.com) - Ausnutria Dairy (1717) issued an announcement yesterday to inform the Company's shareholders and potential investors that the Group expects to record a notable year-on-year ("YoY") decrease in revenue and net profits for the six months ended 30 June 2022.The Group's revenue for the 1H 2022 is anticipated to achieve approximately RMB3,350 million to RMB3,500 million, representing a YoY decrease of 18.0% to 21.6%. The Group also expects to record the profit attributable to equity holders of the Company for the 1H 2022 in the range of RMB95.0 million to RMB160.0 million, representing a YoY decrease of 73.1% to 84.0%. Such decrease is mainly attributable to the decrease in revenue from the Own-branded Cow Milk Powder, owing to the Group's active adjustment of distribution channels in response to market changes as well as the macro-environmental factors.Due to lower birth rate in Mainland China and stringent anti-epidemic measures in some regions, the infant formula industry faced unprecedented challenges in 1H 2022. According to AC Nielsen, the industry's sales level for the period from January to April 2022 decreased by 4.4% YoY, and the sales volume decreased by 6.2% YoY, showing an overall downward trend. However, benefiting from Hyproca 1897's outstanding product quality and successful brand-building efforts over the years, at the retail level, Ausnutria's market share in term of sales maintained a steady growth in 1H 2022. Data from the same market research revealed that the market share of Hyproca 1897 for the period ended 30 April 2022 increased YoY by 0.5 percentage points, and revenue generated from Kabrita still outperformed the market.With a compound annual growth rate ("CAGR") of 34.1% for the last five years, the Group's Own-branded Cow Milk Powder has experienced significant growth since its establishment. The Hyproca 1897 business unit recorded an even sharper five-year CAGR of 61.7%. The estimated decrease in revenue for 1H 2022 is mainly due to the provision of products with better shelf life and of higher quality to customers, as well as the active adjustments made to reduce inventory pressure of major distributors and channel partners. Since the end of 2021, the Group has been enforcing more stringent control over the total inventory level of its distribution channel by slowing down the delivery of the Own-branded Cow Milk Powder to distributors. Indeed, our Own-branded Goat Milk Powder experienced a short-term and one-off proactive adjustments in its distribution channel in 2021. The results showed the Group's channel management, distributor co-operation and brand power are strengthening and becoming more resilient. The Own-branded Goat Milk Powder in the People's Republic of China (the "PRC") resumed double-digit YoY growth in 2021. Furthermore, the adjustment is expected to be completed in the third quarter of 2022. With the adoption of channel adjustments and overall improvement in products, branding and servicing, the Group is confident that Hyproca 1897 will fully return to solid growth in 2H 2022. Regular improvements with foresight planning are the key to staggering long-term results. The Group prioritizes the long-term development principle in the Company's growth through carrying out business activities based on the needs of consumers and distributors while pursuing the development of a healthy industry ecosystem. The Group believes inventory pressure can be reduced by active adjustments and collaboration with distributors. Consumer rights and distributors' confidence can hence be protected and enhanced respectively, as the Company lays the foundation for long-term development and brings more far-reaching returns to shareholders.About Ausnutria Dairy Corporation LtdAusnutria Dairy Corporation Ltd is a leading infant milk formula company with production facilities principally based in the Netherlands, the PRC, Australia and New Zealand. The Company is engaged in the worldwide production, R&D, and sales of infant formula, adult milk formula and other dairy and nutrition products. It owns several famous infant formula brands, including "Kabrita", "Allnutria" and "Hyproca". Ausnutria's factories in the PRC were among the first batch of factories that had been granted with the National Infant Formula Enterprise Production Permit. The factories in the Netherlands and Australia of Ausnutria were also among of the first infant milk formula manufacturers to obtain import licenses for overseas products under the new policy in the PRC. Copyright 2022 ACN Newswire. All rights reserved. (via SEAPRWire)

31 3 月, 2022

Weimob (2013.HK) Smart Retail sends SaaS revenues soaring 90.9%

SHANGHAI, Mar 31, 2022 - (ACN Newswire via SEAPRWire.com) - Weimob Inc (2013.HK) released its 2021 financial report earlier this week (3-28), showing that its adjusted total revenue in 2021 reached 2.686 billion yuan, a record high, and its performance increased by 36.4% against the background of overcoming unfavorable factors such as downward pressure on the macro economy. After adjustment, the gross profit of RMB 1.517 billion increased by 51.3% year on year. Among them, the digital business sector achieved revenue of 1.967 billion yuan, an increase of 70.9% compared with 2020. Subscription solutions and merchant solutions in this sector achieved high growth of 90.9% and 47.5% respectively. The "WOS" new business operating system developed by Weimob Inc has been officially put into beta this month, and it may become a powerful engine to drive the future growth of Weimob Inc.High-speed growth of business; SaaS revenue grows against the trendIn 2021, the persistence of the epidemic brought many challenges to consumers and To B enterprises. Weimob Inc focuses on the digital transformation and upgrading of enterprises, continuously strengthens the development of multi-product lines, further promotes the three strategies of "customization, ecology and internationalization", overcomes the adverse effects of external environment, and achieves the contrarian growth of performance. The financial report shows that the digital business income of Weimob Inc in 2021 was 1.967 billion yuan, an increase of 70.9% compared with 1.246 billion yuan in 2020. Among them, the revenue of Weimob Inc subscription solution (SaaS sector) reached 1.188 billion yuan, a substantial increase of 90.9% year-on-year. The number of paying merchants was 102,813, a year-on-year increase of 5.0%. The average income per user increased by 57.7% to 11,553 yuan.At the same time, with the continuous promotion of TSO's full-chain marketing solution, the business solutions in the digital business sector of Weimob Inc have achieved good results. The financial report shows that in 2021, the business solution revenue was 779 million yuan, a year-on-year increase of 47.5%; The gross income of accurate delivery was 10.95 billion yuan, a year-on-year increase of 12.1%. The number of paying merchants increased by 26.7% to 57,909, and the average income per user was 13,454 yuan.The financial report shows that the R&D expenditure of Weimob Inc in 2021 was 775 million yuan. Among them, the total investment of strategic projects such as the new business operating system WOS and the construction and operation of the middle platform reached 682 million yuan. Due to the increased investment in R&D and the merger and acquisition of Xiangxinyun and Haiding in 2021 and previous years, Weimob Inc lost 566 million yuan in adjusted net profit in 2021. However, these investments promote the cost reduction and efficiency increase of Weimob Inc. The financial report shows that the company has abundant cash flow, with cash and cash equivalents of 3.809 billion yuan, and its financial structure is healthy and sustainable.The strategy of customization has achieved fruitful results, and internationalization has steadily advancedThe financial report shows that the reason why Weimob Inc achieved high revenue growth in 2021, benefiting from the core strategy of "customization, ecology and internationalization" of the group. With the support of TSO's full-chain marketing solution and smart retail and other key businesses, Weimob Inc's customization strategy achieved fruitful results. In the smart retail sector, in 2021, Weimob Inc's smart retail revenue was 426 million yuan, 193.6% year-on-year, and its share in subscription solution revenue further increased from 20.2% in 2020 to 36%. At present, the number of smart retailers in Weimob was 6,126, the number of brand merchants was 1,003, and the average order income of brand merchants per user was 234,000 yuan.The Weimob smart catering business also achieved a breakthrough. In 2021, Weimob Smart Catering completed the technical and operation system layout of "three stores integrated and global operation". During the reporting period, Weimob's smart catering revenue was 53.616 million yuan, up 19.6% year-on-year, accounting for 4.5% of subscription solution revenue. There were 8,406 smart catering merchants, and the average order revenue per user of catering merchants was 17,000 yuan. By the end of 2021, Weimob smart catering customers accounted for 41% of China's top 100 restaurants; The revenue from catering orders accounted for 51%.Promoting ecology, WOS New Business Operating System as a new growth engineAs one of its three core strategies, Weimob Inc's ecological strategy has also made remarkable achievements. In terms of developer ecology, in 2021, Weimob Cloud PaaS platform will continue to empower ecological partners, with over 50 new high-quality ecological partners and over 400 new cloud market applications.In order to create a good foundation for smart business, the WOS New Business Operating System was officially put into public beta in March 2022. WOS new commercial operating system integrates SaaS business integration, ecological partnership and PaaS platform infrastructure, and realizes the comprehensive upgrade of product strength, technical strength and ecological strength, demonstrating the technical strength of Weimob Inc. In 2022, Weimob will continue to improve WOS product strength, better serve customers through Weimob cloud empowering eco-partners, and drive the growth of product strength and commercial strength by technology, so as to realize faster product development, better product experience and service, and more ecological applications and services, so as to promote customers' purchase, increase customer renewal fees and increase ecological income. CITIC Securities holds that "WOS" is expected to become the new growth driver of SaaS with the improvement of merchant coverage and the acceleration of commercialization.In terms of investment layout, in 2021, Weimob Inc and Yicun Capital jointly established "Weizhi Digital Industry Fund" and invested in outstanding projects such as Shuyun, Haizhi and Meichuang. In November, 2021, Weimob Inc announced the acquisition of 51.89% equity of Shanghai Xiangxinyun Network Technology Co., Ltd., and incorporated Xiangxinyun into the listed company system, thus deepening the digitalization capability of smart retail shopping guide.Weimob Inc said that in 2022, the company will focus on seven directions: focusing on key customers and continuing to lead; Open and win-win, create ecological barriers; TOS full-link operation, helping customers smart grow; Continue to increase investment in private track and consolidate the leading position in the industry; Cloudy layout drives new growth; "7+X" to create a new growth flywheel; Cross-border development and layout of the global market. Under the background of accelerating the digitalization process of Chinese enterprises, Weimob Inc has made sufficient product reserves, technical reserves, talent reserves and capital reserves, laying a solid foundation for the development in the next five years.Media contact:Micky Sun, Weimob IncEmail: jingyi.sun@weimob.comWebsite: http://www.weimob.comWeimob Inc (2013.HK) is the leading cloud-based commerce and marketing solutions provider for SMBs. For information, visit www.weimob.com. Copyright 2022 ACN Newswire. All rights reserved. (via SEAPRWire)

30 3 月, 2022

SF Intra-City Delivers Outstanding Annual Results, Highest Revenue In Third-party On-demand Market

HONG KONG, Mar 30, 2022 - (ACN Newswire via SEAPRWire.com) - Hangzhou SF Intra-City Industrial Co., Ltd. ("SF Intra-City" or the "Company"; stock code: 9699), the largest third-party on-demand delivery service platform in China , today announced its annual results for the year ended 31 December 2021 (the "Year"). Revenue continued to rise with gross profit and gross profit margin turning positive for the first time. The inspiring set of results demonstrates the successful implementation of its business development strategies.Results Highlights-- Revenue surged by 68.8% YoY to RMB8.17 billion-- Gross profit and gross profit margin turned positive, successfully achieving a gross profit of RMB94.8 million and gross profit margin of 1.2% YoY-- Revenue from intra-city delivery service increased by 58.1% YoY to RMB5.09 billion-- Non-food delivery scenarios achieved YoY revenue growth of 105% to RMB1.87 billion-- The number of active merchants increased 54.5% YoY to over 258,000-- The number of active consumers increased from approximately 5.1 million in 2020 to approximately 10.6 million in 2021, doubling YoY. The Company has achieved over 150% YoY growth in terms of revenue for intra-city delivery service to consumers for three consecutive years-- Revenue from last-mile delivery services increased by 89.3% YoY to RMB3.07 billion, accounting for 37.6% of total revenue. The number of cities and counties increased to over 1,900-- With further optimization of scale and efficiency, diversified product coverage and multi-scenario business model, SF Intra-City reported an inspiring set of resultsDuring the Year, revenue surged 68.8% year-on-year ("YoY") to RMB8.17 billion, underpinned by a strong performance from non-food delivery scenarios , diversified product coverage and multi-scenario business model, further expansion of active merchant and active consumer bases, and expansion of service network into lower-tier markets with huge growth potential. The Company achieved higher operational efficiency and lower delivery costs through the continued expansion of its scale and continued investment and optimization of big data and AI technologies in its City Logistics System ("CLS"). As a result, the Company achieved gross profit/loss margin improvements for three consecutive years, recording a gross profit of RMB94.8 million and a gross profit margin of 1.2%. The net loss ratio narrowed to 11% from 15.6% last year.SF Intra-City said, "We are pleased to report an inspiring set of annual results this year. Following our successful IPO at the end of last year, the impressive annual results represent another outstanding milestone in our business development. Over the past year, we have achieved significant growth by expanding our multi-scenario, customer base and geographic coverage. Not only did we continue to grow revenues, but we also managed to achieve positive gross profit and gross margin. This is an excellent result among peers."Business ReviewHigh Growth in Intra-city Delivery ServiceRevenue from Intra-city delivery service increased by 58.1% YoY to RMB5.09 billion, underpinned by a strong performance from non-food delivery scenarios, diversified product coverage and multi-scenario business model, further expansion of active merchant and active consumer bases, and expansion of service network into lower-tier cities with huge development potential. The revenue of non-meal delivery scenarios increased by 105% YoY to RMB1.87 billion, accounting for 37% of the total revenue from intra-city delivery, and the revenue from lower-tier cities increased by 89% YoY to RMB1.67 billion.Intra-city Delivery to MerchantsSF Intra-City empowers merchants with its open and inclusive on-demand delivery network as well as its professional and comprehensive solutions. The number of its active merchants increased 54.5% YoY to over 258,000. SF Intra-City has become the preferred third-party on-demand delivery service provider for its merchant customers. It has achieved remarkable revenue growth in local retail, local e-commerce and local services, with over 165% YoY growth in revenue for merchants deliveries in the pharmaceutical, apparel and 3C electronics industry, as well as over 95% YoY growth in revenue for merchants deliveries including fresh produce, flowers, cakes and desserts and other groceries. In addition, the Company continued to deepen cooperation with leading brands during the year and established friendly business relationships with over 2,300 merchant brands. With the Company's commitment to quality, stability and customer-focused service, the retention rate for Top 100 accounts reached 86% during the year.Intra-city Delivery to ConsumersRevenue from intra-city delivery service to consumers has grown by more than 150% YoY for three consecutive years, driven by a rapidly expanding consumer base. The number of active consumers doubled YoY from approximately 5.1 million in 2020 to approximately 10.6 million in 2021 driven by the professional, reliable, and 24/7 real-time service across all scenarios. The Company's specialized "pioneer riders" continued to improve its delivery standard for consumers, achieving order-pick-up rate of no less than 99% and fulfillment-in-time rate of no less than 96% at the end of 2021.Last-mile Delivery Advantage Further StrengthenedRevenue from last-mile delivery services increased significantly by 89.3% YoY to RMB3.07 billion, with the number of cities and counties covered by last-mile services expanding to over 1,900, underpinned by increasing demand and the Company's efficient fulfillment capabilities to take on more orders. The last-mile delivery service business has further expanded its network and enhanced network efficiency and economies of scale, increasing rider income and loyalty and effectively reducing delivery costs.Technology Empowering Improvements in Riders' Ability to Perform High-Quality ServiceThe Company has made continuous investments in technology to further optimize operational efficiency and reduce delivery costs. Through the utilization of CLS, real-time analysis can be performed on order volume and order density enabling precise adjustments such that riders can deliver orders for different service scenarios throughout the day and cope with real-time order volume volatility, resulting in rider efficiency enhancement.During the Year, the number of our active riders increased 32% YoY to over 606,000. The increase in rider base has enabled SF Intra-City to further expand its existing business while exploring and taking on new business initiatives, including the development of a night-time (24-hour) delivery service network, allowing better service performance and responses to specific customer needs. The Company also maintained its high quality of service, with a fulfillment in-time rate of 95%, successfully driving impressive revenue growth. Particularly for food delivery scenarios (which time is of the essence), SF Intra-City have achieved an average delivery time of 26 minutes per order in 2021. During the Year, the number of cities covered by night-time (24 hours) delivery service network amounted to 693 cities. The Company concluded, "In order to drive business and revenue growth and maintain above industry average growth rates, we have devoted ourselves to cultivating different delivery service scenarios and actively expanded our coverage network and customer base over the years. To reach more merchants and consumers, we expanded our service network from first- and second-tier cities into lower-tier cities that have large growth potential, abundant rider resources and rich sales channels. At the same time, we are actively responding to the ever-changing, complex and diversified needs of consumers, insisting on enhancing customer loyalty through high-quality services, as well as improving customized service and enabling technology empowerment to further optimize service quality. Through efficiency improvements from business optimization and operational refinement as well as deeper market penetration, we believe going forward SF Intra-City will achieve greater economies of scale and network effects, realize profitability and create long-term value for shareholders."About Hangzhou SF Intra-City Industrial Co., Ltd. (stock code: 9699.HK)SF Intra-City focuses on the emerging opportunities of intra-city on-demand delivery services. Since 2019, SF Intra-city has operated as an independent legal entity to capture the growth opportunities arising from the new consumption trends. SF Intra-City adopts a multi-scenario business model, providing full coverage of delivery scenarios for all types of products and services. The Company's extensive service coverage, ranging from mature scenarios such as food delivery to growth scenarios such as local retail, local e-commerce and local services, has enabled it to respond to the evolving customer needs resulting from the development and upgrade of the local consumer market. For more details, please visit company's website: https://ir.sf-cityrush.com/en/investor-relations/.For media enquiries:Christensen China LimitedSuri ChengPhone: +86 185 0060 8364Jenny LamPhone: +852 2232 3928 / +852 6312 2027Email: SFIntracity@christensenir.com Copyright 2022 ACN Newswire. All rights reserved. (via SEAPRWire)

30 3 月, 2022

Dynasty Fine Wines 2021 Revenue Rises Notably by 28% to HKD306 Million Due to Successful “5+4+N” Product Strategy

HONG KONG, Mar 29, 2022 - (ACN Newswire via SEAPRWire.com) - Dynasty Fine Wines Group Limited ("Dynasty" or "the Group") (Stock Code: 828), a premier grape winemaker in China, today announced its audited annual results for the year ended 31 December 2021. Revenue in 2021 increased by 28% year-on-year to HK$306 million. Gross profit rose by 103% year-on-year to HK$121.9 million. Gross profit margin increased significantly from 25% in 2020 to 40% in 2021. Profit attributable to owners of the Company was HK$32.8 million in 2021, a decrease when compared with HK$116.4 million in 2020. The decline was due to a net gain (after tax) of HK$183.7 million from a disposal, which was a one-off transaction, recorded in 2020. If the net gain of the one-off disposal in 2020 was excluded, profit attributable to owners of the Company would have increased significantly in 2021 versus the preceding year.In 2021, the revenue of wine products grew, mainly due to a marked increase in sales volume of products, especially middle to high-end wine products, after optimization of the Group's product mix, as well as the increase in market price of certain upgraded and custom-made products during the year. In the second half of 2021, the occurrences of flooding and heavy rain and sporadic COVID-19 cases in certain regions of China adversely affected consumer sentiment. Consequently, the Group's revenue growth for the full 2021 financial year slowed relative to the first half year.The total number of bottles of wine sold in 2021 was approximately 11.9 million, an increase of 20% as compared with 9.9 million bottles in 2020. Red wines continued to be the Group's primary revenue contributor, accounting for approximately 51% of the Group's revenue for the year (2020: 65%). White wine sales became the growth driver of the Group, which surged by approximately 60% year-on-year and accounted for 40% of the Group' revenue. In 2021, the gross margin of red wine products and white wine products were 37% and 47%, respectively (2020: 24% and 31%, respectively).The Group produced a wide range of more than 100 wine products under the "Dynasty" brand. This has enabled it to meet the demands and preferences of different consumer groups, mainly in the mass segment of the Chinese wine market. During the year, the Group launched a new premium product, Dynasty Chinese Zodiac Commemorative Dry Red Wine, for the Xin Chou Year of the Ox, integrating high quality with the Chinese zodiac culture. The Group also unveiled two new product series, namely "Sweet Heart" and "Pleasant Color", for the entry-level product segment. The product series are targeted at young consumers and will open a new chapter as part of the Group's product rejuvenation strategy. The Group also sold foreign branded wines during the year. Imported mainly from France, Italy, Australia, Chile and the United States, the wines enter the Chinese market through the Group's existing distribution network. Having streamlined its portfolio, the Group currently sells about 50 imported grape wine products under approximately 10 brands.During the year, the Group strengthened cooperation with distributors to operate online stores on such e-commerce platforms as JD.com, Tmall and Pinduoduo. Moreover, innovations were achieved across its brands and product categories, as well as business systems, procedures and models via new retail platforms including Weibo, RED (Xiaohongshu app), Kuai (Kuaishou app) and TikTok (Douyin app). The Group also established an e-commerce team and actively cultivated e-commerce live broadcasting talent to further expand its sales channels and build up a new customer base.In October 2021, Dynasty held a grand opening ceremony in the new premises of its National-level Technology Center. The work station in the Center has commenced research for the first time on the selection of distinctive muscat yeast in order to create more mellow and enjoyable wines. Also, Dynasty Technology Center established a winemaking and wine tasting studio during the year.In 2021, Dynasty continued to implement its market demand-oriented "5+4+N" product strategy, and completed the enhancement of the Group's organization structure. In the Group's strategy, "5" represents the five key series of products, comprising air dry series, seven-year reserve series, merlot series, classic series and best-selling series, and represents the goal of having full coverage of all mainstream price segments; "4" refers to the four advantageous categories, i.e. dry red wines, dry white wines, brandy and sparkling wines, and the aim of increasing the Group's vertical market share; and "N" stands for the development of "N" kinds of customized products to meet the diversified needs of Chinese consumers. In 2021, the Group achieved remarkable results from the adjustment of its products, sales channels and marketing campaigns. With respect to its large-scale marketing campaign, the Group forged ahead with various endeavors, including showcasing products in 20,000 shops, hosting 1,000 wine tasting events and organizing 100 plant visits, so as to continue developing its point-of-sale network. In the coming three years, the Group will strive to deploy 100,000 points of sale, add 1,000 distributors, and vigorously develop new channels via retail platforms. This will enable the Group to seize opportunities from the growing consumption market driven by young adults, and achieve the annual sales target of over RMB1 billion.Mr. Wan Shoupeng, Chairman of Dynasty, said, "The Group is pleased that the "5+4+N" strategy has been effective in boosting product sales in 2021, which in turn has facilitated overall revenue growth. In the future, the Group will increase its investment in brand development in order to fully vitalize its brands as well as drive development of its major products. The latter will involve steadily enhancing quality and controlling prices to boost sales volume, with the aim of bringing Dynasty's superior wines to more consumers in China. Furthermore, in line with the industry development trend, Dynasty will strengthen its presence in the mass-market and mid-range product segments as well as target young consumers. In spite of the possible impact brought by sporadic COVID-19 cases in China, the Group is confident that its annual revenue will maintain a steady growth trend in 2022." Copyright 2022 ACN Newswire. All rights reserved. (via SEAPRWire)

28 3 月, 2022

EEKA Fashion Announces 2021 Annual Results, Double-digit Revenue and Profit Growth Driven by Multi-Brand Strategy

HONG KONG, Mar 28, 2022 - (ACN Newswire via SEAPRWire.com) - EEKA Fashion Holdings Limited (Ticker: 3709.HK, "EEKA" or "the Group") announced unaudited consolidated annual results for the year ended 31 December 2021 ("the period"). In 2021, the Group's revenue increased 19.3% year-on-year to RMB6.4 billion. Gross profit was RMB4.8 billion, representing an increase of 21.2% year-on-year. The gross profit rate was 74.6%. Net profit increased by 28% to RMB562 million.Mr. Jin Ming, Founder and CEO of EEKA Fashion, said "Based on EEKA's multi-brand strategy, we are committed to providing high-quality products to meet our customer's needs, to further empower the intellectual, elegant, and modern styles for women. EEKA focuses on enhancing our core operational capabilities through innovative research and design, supply chain digitalization, and membership management. With our platform-based multi-brand strategy, we will continue to grow our business amid positive market outlooks, and to fuel the innovations within the industry with our leading position. With that, we are confident in achieving the goal of exceeding 10 billion retail sales by 2023."During the period, the Group recorded strong double-digit revenue growth for the eighth consecutive year based on the success of multi-brand strategy with its mid- to high-end womenswear brand matrix. The Group is the first in the market to build three RMB1 billion retail sales brands. Two high-end brands Koradior and NAERSI achieved a combined revenue of over RMB3.7 billion, maintaining as the Group's top revenue contributors. NEXY.CO hit RMB1 billion in retail sales for the first time, and revenue recorded at RMB872 million. The youngest brand FUUNNY FEELIN targeting mid-end market also achieved revenue of over RMB100 million, with an impressing growth rate of over 100%.The Group sustained its growth momentum by continuous operations improvement of its offline retail channels and online e-commerce platforms. EEKA leveraged its competitive advantages in the retail stores, achieving sales close to RMB5 billion, accounting for around 80% of the Group's total revenue. As of 2021, EEKA operated over 1,500 retail stores, with a membership base over 3.6 million, which will help to enhance the Group's revenue growth in long-term. During the period, revenue of e-commerce platforms increased by 23.6% to RMB757 million. While sales from Tmall and VIP.com continued to grow, EEKA Fashion Mall and Douyin channels also became key revenue drivers for the Group, each recording a growth rate at over 200% and 1,400%. Based on strong brand operating capabilities accumulated for over 20 years, EEKA will continue to solidify its edge from platform-based strategy through digitalization across design, production, marketing and sales. The Group is dedicated to product innovations to offer high-end fashion for customers. Meanwhile, the Group launched digital projects surrounding supply chain optimization and centralized management of membership and product data to further enhance overall efficiency. In 2021, EEKA actively promoted sustainable development, joining "The Smart Coalition for Sustainability" with its eight womenswear brands. The Group also launched "EEKA Prize" to develop young talents in China and promote innovative design for sustainability.In the future, the Group will continue to enhance its leading position in China's fashion industry, with a clear goal of exceeding 10 billion retail sales by 2023 and 15 billion retail sales by 2025. EEKA will further increase the brand's market influence, digitalization and innovation capabilities based on the strategic focus of "multi-brand and multi-channel". With the vision of "Just for her unique glamour", the Group is committed to creating value for consumers in pursuit of a better life, consolidating its leading position of middle and high-end women's apparel market in China.Note 1: The Group acquired 65% and 35% of the equity interest of Mondial on 13 July 2016 and 10 November 2021 respectively which has self owned brand "CADIDL". Mondial is an insignificant subsidiary of the Company within the meaning of the Listing Rules.Note 2: The Group acquired the assets of SK Networks (China) Fashion Co. Ltd. (including fashion products under the brand names "Obzee" and "O'2nd") on 9 March 2017 and terminated an exclusive distribution agreement in April 2020.Note 3: The Group acquired 100% of the equity interest of Keen Reach which has self-owned brand"NAERSI", "NEXY.CO" and "NAERSILING" on 3 July 2019.About EEKA FashionEEKA Fashion Holding Limited (Stock Code: 3709.HK) is a well-known fashion apparel group with a unique brand culture concept, advanced research and development design center, sound marketing service system, efficient logistics distribution and network management system. The Company has been deeply involved in China's high-end women's apparel industry since its establishment and was listed on the Hong Kong Main Board in 2014. The Group currently has eight self-owned brands: Koradior, La Koradior, Koradior elsewhere, NAERSI, NAERSILING, NEXY.CO, CADIDL and FUUNNY FEELLN. Over the years, EEKA Fashion Group has been strongly committed on brand internationalization. Since 2015 onwards, many of its brands have been invited to Milan Fashion Week and New York Fashion Week to show the charm of Chinese brands. The Group has always insisted that brand is the root and creativity is the soul, based on customer lifestyle research and brand culture shaping, in view of customer needs and the mission of "Just for her unique glamour", focusing on product innovation and brand communication, and continuing to lead customers' dress and life culture.This press release is issued by ICA Investor Relations (Asia) Limited on behalf of EEKA Fashion Holdings Limited. For any enquiries, please contact:ICA Investor Relations (Asia) Limited Tel: +86 (21) 8028-6033E-mail: eeka@icaasia.com Copyright 2022 ACN Newswire. All rights reserved. (via SEAPRWire)

25 3 月, 2022

Analogue Achieves Revenue and Net Profit Growth to HK$5,351 Million and HK$314 Million Respectively Despite Adverse Market

HONG KONG, Mar 25, 2022 - (ACN Newswire via SEAPRWire.com) - Analogue Holdings Limited ("Analogue" or the "Company", together with its subsidiaries, collectively the "Group") (stock code: 1977), a leading electrical and mechanical ("E&M") engineering service provider in Hong Kong, today announced its annual results for the year ended 31 December 2021 ("the Year" or "FY2021") with revenue and net profit growth, posting a solid performance amid the pandemic and global uncertainty.Highlights-- Total revenue reached HK$5,350.7 million, an increase of 10.8% compared with adjusted revenue in FY2020-- Profit attributable to owners of the Company grew 4.3% year-on-year to HK$314.3 million-- Revenue from maintenance services increased 7.2% to HK$945 million-- High dividend payout ratio maintained at 50.2%During the Year, the Group's total revenue increased by 4.4% year-on-year to HK$5,350.7 million, mainly driven by both Building Services and Environmental Engineering segments. After adjusting the revenue for FY2020 from Transel Elevator & Electric Inc. ("TEI"), which has been reported as an associate of the Group since August 2020, the Group's total revenue would have increased by 10.8% year-on-year. In particular, revenue from maintenance services, a source of recurring income, increased by 7.2% year-on-year to HK$945 million, accounting for an increased proportion to 17.7% of the total revenue. Gross profit amounted to HK$878.4 million, with gross profit margin at 16.4%. Profit attributable to owners of the Company grew by 4.3% year-on-year to HK$314.3 million, even in the absence of such wage subsidies as the Government's "Employment Support Scheme" in 2020, which is evidence that the Year is most encouraging. The Board has proposed a second interim dividend of HK7.25 cents per share. Together with the first interim dividend of HK4.02 cents per share, the total dividend for the Year amounted to HK11.27 cents per share, representing a high dividend payout ratio of 50.2%.The Group has drawn on its exceptional project execution capability to deliver on the order book throughout 2021. Contracts-in-hand reached approximately HK$11,309 million as at 31 December 2021. Tendering activities remained active during the reporting period, with a total of 1,676 tenders valued at over HK$1 million each. Dr. Otto Poon Lok-to, Chairman of Analogue Holdings Limited, said, "In 2021, although the E&M engineering sector was less affected by COVID-19 when compared with other industries, we still faced various challenges, such as interruptions in tendering for public works projects, high material and labour costs, etc. At Analogue, we upheld our motto 'We commit, We perform, We deliver' while doubling efforts to overcome challenges, which included optimising all facets of operation. In terms of business mix, we intentionally increased the proportion of contributions from maintenance services to ensure a stable source of income. Regarding geographical expansion, we leveraged our successful track record in Hong Kong, Macau and Mainland China to establish footholds overseas. As an advocate of innovation, we continued to direct our efforts towards enriching business operations through applications of new technologies. Our strategies have resulted in increased revenue and profitability in FY2021 despite the testing environment."With active project delivery throughout the Year, Building Services segment's contracts-in-hand reached HK$4,892 million as of 31 December 2021. As an early adopter of cutting-edge building technologies, the Group pioneered the first high-rise building in Hong Kong using the advanced Modular Integrated Construction ("MiC") method. This track record won it HK$150 million worth of MiC contracts in FY2021. In light of the surging demand for MiC, the Group has been expanding its Multi-trade Integrated Mechanical, Electrical and Plumbing ("MiMEP") facilities and developing its proprietary ATAL Building Services Prefabrication and Modularisation Construction Technology ("ABSPM") to further improve the speed, cost, safety, and quality of construction work. During the Year, the Group participated in the building services work for one of the biggest data centres and secured additional installations and maintenance projects from major data centre operators in Hong Kong. Other key projects secured include a major hospital term contract and seven residential projects worth approximately HK$800 million, as well as a major contract for a Hong Kong racehorse training facility located in Guangzhou.Environmental Engineering segment's contracts-in-hand amounted to HK$4,977 million. During the Year, the Group won four term contracts for the Hong Kong Government's Water Supplies Department that brings citywide benefits, covering all waterwork installations throughout the territory, such as the maintenance of mechanical and electrical equipment, instrumentation equipment, water quality monitoring equipment and plants. In addition, the Group took part in the iconic project of the Hong Kong Government Drainage Services department to upgrade the existing sewage treatment works to become the effluent polishing plant in Yuen Long which has been upgraded to meet future development needs, including expanding the treatment capacity from 70,000m3/day to 150,000m3/day. The deployment of the most advanced sewage treatment technologies featuring green design and community provisions will create an exemplary community asset and a more sustainable Hong Kong. The Group also commenced the operation and maintenance works for the sewage treatment plants in San Wai and power stations in Castle Peak and Black Point during the Year. Information, Communications and Building Technologies ("ICBT") segment's contracts-in-hand increased by 2.7% to HK$877 million during the Year. To contribute to the development of Hong Kong's "Smart City" and "Smart Economy" initiatives, the Group rolled out a number of ICBT projects, including its proprietary Internet of Things ("IoT") applications for Smart Washrooms, Retro-commissioning (RCx) of electrical and mechanical systems, Indoor Environmental Quality (IEQ) Monitoring, Indoor Positioning and Video Analytics, as well as its in-house developed Cloud-based AI Energy Management Platform during the Year. In particular, the AI Energy Management Platform, IoT applications and Video Analytics technology have been chosen by more than 20 shopping malls, while its Photovoltaic ("PV") systems will be installed in more than 100 schools and NGOs. Such continuous contributions to streamlining digital processes and applying them will ultimately benefit society and advance the Smart City development in line with the government's blueprint.The Lifts and Escalators segment's contracts-in-hand amounted to HK$563 million. During the Year, Anlev Elevator Group ("Anlev"), the Group's global brand of lifts, escalators, and moving walkways, completed the installation of Hong Kong's first commercial puzzle-stacking automated parking system, which advances "Smart Mobility" in Hong Kong, with the form of flexible automated parking system (APS). Designed by Anlev, the APS leverages innovative technology to provide 30 to 100 percent more parking spaces within the same footprint to alleviate the shortage of parking space in Hong Kong, enhance traffic planning and bring greater convenience to motorists. Following the success of the first APS project, Anlev was awarded a further contract to provide an APS for the new government building in the Kai Tak Development Area. For overseas markets, the alliance with TEI, one of the largest independent lift and escalator companies in New York, effectively enhanced the Group's operational and technical capabilities, and widened its service offering to international customers. The Group's new market strategy is also evidenced by the establishment of its first lifts and escalators company in the United Kingdom."On the green initiatives front, I am pleased that the Group has become the first E&M engineering group in Hong Kong to obtain a Sustainable Finance Certification from the Construction Industry Council and achieve the Green Loan Pre-Issuance Stage Certificate under the Green and Sustainable Finance Certification Scheme launched by the Hong Kong Quality Assurance Agency, as well as issuing a green financing instrument that will go towards enhancing water and wastewater management. In continuing this green journey, we are actively collaborating with prominent universities to develop more green energy and innovative environmental solutions," added Dr Poon.In 2022, despite the emergence of the fifth wave of COVID-19 in Hong Kong having hampered the pace of economic recovery, on-going significant investments in infrastructure, the "Smart City" initiatives, the rise of IoT, as well as the rapid development of the Greater Bay Area are expected to present tremendous opportunities to Analogue. The outlook remains positive for the Group, which has been able to focus on its well-established foundation and innovative culture to sustain the operation through the uncertainties. Dr Poon concluded, "Good opportunities arise even amidst challenging times. With strong business fundamentals and a sound financial position, we are well-positioned to grasp the growth opportunities ahead. Apart from organic growth, we will continue our efforts in exploring M&A opportunities in different parts of the world to support our expansion plans, with priorities placed on companies that have synergistic effects. 2022 marks the 45th anniversary of the Group. Over the past decades, we have dealt with numerous challenges, and have grown stronger from such experiences. With our pioneering spirit, utmost determination, wealth of experience and solid foundation, we are confident in achieving our expansion plans and propelling Analogue to new heights."For more details of the 2021 Annual Results, please refer to the announcement that has been filed with The Stock Exchange of Hong Kong Limited.https://www1.hkexnews.hk/listedco/listconews/sehk/2022/0325/2022032501168.pdfAbout Analogue Holdings LimitedEstablished in 1977, Analogue Holdings Limited is a leading electrical and mechanical engineering service provider headquartered in Hong Kong, with operations in Macau, Mainland China, the United States and the United Kingdom. Serving a wide spectrum of customers from public and private sectors, the Group provides multi-disciplinary and comprehensive E&M engineering and technology services in four major segments, including Building Services, Environmental Engineering, Information, Communications and Building Technologies ("ICBT") and Lifts & Escalators. The Group also manufactures and sells Anlev lifts and escalators internationally and has entered into an alliance with Transel Elevator & Electric Inc. ("TEI Group"), one of the largest independent lifts and escalators companies in New York, the United States. The Group's associate partner, Nanjing Canatal Data Centre Environmental Tech Company Limited (603912.SS), is specialised in manufacturing of precision air conditioners. Copyright 2022 ACN Newswire. All rights reserved. (via SEAPRWire)

25 2 月, 2022

Leon Fuat Berhad’s Q4 Profit After Tax Jumps 61.8% to RM29 Million

Group’s financial performance supported by higher gross profit margin resulting from higher average selling prices SHAH ALAM, Malaysia, Feb 25, 2022 – (ACN Newswire) – Leon Fuat Berhad (“Leon Fuat” or the “Group”), a manufacturer and trader of steel products, specialising in rolled long and flat products today released the Group’s financial results for the fourth quarter ended 31 December 2021 (“Q4FY2021”) recording 61.8% growth in profit after tax (“PAT”) to RM29.09 million compared with RM17.98 million in the corresponding quarter of the preceding year (“Q4FY2020”). Calvin Ooi Shang How, Executive Director of Leon Fuat The Group is pleased to note that for the quarter under review, revenue increased by 27.8% to RM254.21 million compared with RM198.96 million in Q4FY2020 while profit before tax (“PBT”) recorded a 106.5% increase to RM38.61 million compared with RM18.70 million. On a segmental basis, revenue from trading of steel products registered a 26.5% increase to RM81.95 million while revenue from processing of steel products recorded a 28.4% rise to RM172.18 million. The trading segment’s contribution to revenue stood at 32.2% in Q4FY2021 compared with 32.6% in the corresponding quarter of FY2020 while the processing segment’s contribution stood at 67.7% compared with 67.4% in Q4FY2020. For the financial year ended 31 December 2021 (“FY2021”), PAT grew 377.6% to RM135.98 million compared with RM28.47 million in the preceding financial year. PBT increased 418.1% to RM172.85 million compared with RM33.36 million while revenue gained 50.4% to RM886.58 million compared with RM589.58 million registered in FY2020. Calvin Ooi Shang How, Executive Director of Leon Fuat said, “The Group’s financial performance for the quarter under review was supported by higher revenue and better gross profit margin from the rise in average selling prices in both the trading and processing of steel products. For the financial year as a whole, revenue was also supported by higher overall average selling prices that also resulting in better overall gross profit margin”. “We are maintaining our cautious outlook for 2022 on downside risks arising from decelerating economic growth amid continued COVID-19 flareups across the world, diminishing policy support and lingering supply bottlenecks. While the Malaysian economy is expected to grow by 5.5% to 6.5% this year on continued external demand and private sector expenditure, we note concerns over new virus variants, inflation and financial stress that could weigh on economic recovery too”. “We will continue to monitor the movement of steel prices as we anticipate commodity price volatility due to global factors. Our monitoring will also continue for foreign currencies while negotiating forward contracts where necessary and having prudent inventory management. The Group will continue to actively address COVID-19 concerns by adhering strictly to standard operating procedures and having in place emergency response teams in three of our major subsidiaries”.

25 2 月, 2022

PIL’s Revenue Hit All-Time High for FYE 2021

HONG KONG, Feb 25, 2022 - (ACN Newswire via SEAPRWire.com) - Pentamaster International Limited ("PIL" or "the Group") which is listed under the Main Board of The Stock Exchange of Hong Kong Limited announced its financial results for the year ended 31 December 2021 today. The Group hit a new record in its 2021 revenue, registering at MYR508.1 million, whilst its net profit stood at MYR116.7 million for financial year ended 2021; marking an improvement of approximately 21.4% and 2.5% respectively from the corresponding period last year.the performance of the respective operating segments, which includes elements of the inter-segment transactions during the yearThe overall performance of the Group recovered commendably in 2021, with growth driven by improved contributions from both the ATE and FAS business segments with each segment accounted for approximately 70.1% and 29.9% of the total Group's revenue, as compared to 2020 of 67.6% and 32.4%, respectively.ATE segmentWith a revenue contribution rate of 70.1%, the ATE segment continued to contribute the larger portion of the Group's overall revenue and profit. After witnessing a decline in revenue last year, total revenue from this segment marked a turnaround and grew at a double-digit rate of 22.6% to MYR358.4 million. During the year, backed by the recovery of the smartphone market and its peripheral items. the electro-optical industry continued to dominate the ATE segment with its revenue contribution rate of approximately 49.7%, derived from a broadproduct portfolio of the Group in its test solutions for proximity sensor, 3D magnetometer sensor, ambient light sensor, wafer level VCSEL (Vertical Cavity Surface-Emitting Laser) and other relevant applications under optics and photonics sensing solutions.Owing to the Group's persistent effort in increasing its exposure to the automotive industry, revenue from this sector came in as the second highest within the ATE segment with its contribution rate of 27.6%. In addition, the automotive sector chalked the highest growth rate at 39.9% among other industry sectors within the ATE segment. This strong demand was largely attributed to the Group's automotive test solutions covering a full range of assembly and test technologies for various aspect of the manufacturing process ranging from component test, final test to packaging. During the year, the ATE segment was also benefitted from the semiconductor industry with its revenue contribution rate of 20.0%, where this sector captured a 26.8% growth as compared to 2020 from the continuous demand for the Group's test handling equipment which was underpinned by the growth of integrated chips and other related semiconductor contents from the acceleration of digital transformation by the pandemic over the past two years.The ATE segment will continue to dominate the performance of the Group in the foreseeable future. With the global pandemic unleashing the unprecedented wave of technology developments coupled with the power and momentum of technology convergence, the Group is in a promising position to leverage on these significant opportunities in the ATE segment.FAS segmentAfter recording a strong revenue growth in year 2020, the FAS segment continued to witness double-digit growth rate in its contribution to the Group's revenue, chalking 12.3% growth to achieve MYR155.3 million during the year. This was mainly driven by the robust demand for the Group's proprietary i-ARMS solutions, where a wider customer base adopted this application across different industry segments in different countries and region. Notably, this segment gained its revenue momentum in the third and fourth quarter of the year, with revenue in second half of the year exceeding its first half by approximately 19.5%. The main industry segment that led to FAS growth was the consumer and industrial product segment, contributing approximately 45.4% to overall FAS segment revenue. This followed by the electro-optical segment and medical device segment with its respective revenue contribution rate of 30.4% and 19.3% where application of the Group's i-ARMS was equally prevalent inthese segments.The Group continues to witness huge potential and opportunities in its FAS segment given the fundamental shift towards factory automation and smart manufacturing across various industries especially in a post-pandemic environment. With the current automation trend, the Group will continue to broaden and enrich the capability of its automated solutions to capture the growth from these developments in the years ahead.Outlook"It is not the strongest of the species that survive, nor the most intelligent, but the one most responsive to change."The COVID-19 pandemic has dramatically and fundamentally altered the way we live and work. From social distancing, quarantine, closed borders, travel bans to the buzzword "home office" have never been mandated on such a large scale. The Group, however, navigated the "unsettling" effects of the pandemic and ended the financial year relatively "healed". Such accomplishment has demonstrated the Group's resilience in taking on the undeniable challenges that demand new ways of operating in a post pandemic business environment and its versatility and speed in emerging strongly owing to the hard work and concerted efforts of the employees of the Group.As the saying goes, every cloud has a silver lining. The pandemic has pushed many companies over the technology tipping point and with the surge in automation, digital adoption has taken a quantum leap across many companies and industries. As a result of these developments, the Group embraces 2022 with increased optimism on the back of a strong order book momentum largely driven by another high growth potential year surrounded by several catalysts brought about by AI, big data analytics, IoT, self-driving cars, Industry 4.0 and the deepening application of 5G. With the electro-optical segment currently dominating the Group's financial performance, this segment will continue its growth momentum in 2022, albeit modestly, given the Group's growing exposure to other industry segments. In respect of the automotive segment, the Group expects to witness the continuous affluence of this segment with e-mobility emerging at an accelerated pace. With electrification playing an important role in the transformation of the transportation industry and thereby presenting major opportunities in all vehicle segments, the global transition specifically towards electric vehicles ("EV") continues to get momentum and creates major disruption in the automotive industry and the related nexus. Significant efforts are witnessed through regulator worldwide defining more stringent emissions target which include, among others, the European Union CO2 emissions regulations for cars and vans, China's New Energy Vehicles (NEV) mandate and Biden's administration in introducing a 50% EV target by 2030. Given this context, the Group anticipates a favourable prospect for its automotive test solutions from front-end to back-end which will continue to provide an impetus to the Group's overall performance.In the belief that there is so much room and business opportunity for further expansion and that now is the best time to be planning for the future, the upcoming new manufacturing plant will pave the way for the Group to deepen its foothold in the medical device segment and bring the growth of its FAS segment to the next level. Key technologies that have been used widely in industrial manufacturing are seen to be filtering into the healthcare sector and with AI conquering the next frontier of the medical segment, the automation opportunity within this horizon is now abundant. With these technology developments presented, the Group is heartened to witness the growing demand for its automated assembly solutions from a broader customer base within the medical device segment on the back of an encouraging booking momentum. Together with the setup of Pentamaster MediQ Sdn. Bhd. for its involvement in the manufacturing of single-use medical devices, the Group is fully prepared for the huge market opportunities in the medical industry. Having continuously witnessed revenue growth from the FAS segment in the past two years, the Group continues to benefit from the increased focus of various industries on industrial automation which is now rapidly necessitated by the effects of the pandemic. As the surge in automation continues in the coming years with the use of AI and IoT in the manufacturing processes, the huge potential and opportunities in the FAS segment will be prevalent. Girded by a year of relatively stable financial performance in 2021, the Group will continue to focus fundamentally on its operational capabilities and remain proactive in the development of new cutting edge technologies and solutions. With a wide variety of challenges and opportunities confronting 2022, the Group, having the pulse on the global trends and requirements, is forward-looking in building another year of solid business growth. As it is, the virus is here to stay for a period of time and will be a reality in our daily lives. The Group's priority is to ensure the safety of its employees with its strict adherence to the necessary safety measures and operating procedures.About Pentamaster International LimitedPIL (HKEX stock code: 1665) is a leading global supplier in providing automation technology and solutions to multinational manufacturers mainly in the semiconductor, automotive, electrical & electronics, medical devices and consumer industrial products sectors spanning APAC, North America and Europe. The Group's broad range of integrated automation products and solutions entails innovating, designing, manufacturing and installing automated equipment and/or automated manufacturing solutions. To learn more about PIL, please visit us at www.pentamaster.com.my. For media enquiries, please contact: Email: investor.relation@pentamaster.com.my Copyright 2022 ACN Newswire. All rights reserved. (via SEAPRWire)

21 2 月, 2022

HYPEBEAST LTD. (0150.HK) Ventures Into New Interest Areas Amid Strong Growth Dynamics

HONG KONG, Feb 21, 2022 - (ACN Newswire via SEAPRWire.com) - The board of directors of Hypebeast Limited (Stock Code: 0150.HK) has announced the Group's unaudited key financial results for the three months ended 31 December 2021 ("FY2022 Q3"). The Group started the Financial Year on a high note and continued momentum in FY2022 Q3 with a strong emphasis on realizing strategic and geographical expansion initiatives to capitalize on new business opportunities. In particular, the Group has executed a multi-layered diversification strategy, including content generation in new interest areas such as art and sports, the continued expansion of advertising capabilities offered by the Group's Media segments, and product expansion on the E-Commerce and Retail segments, all of which have energized existing consumers and paved the way for future business growth.As the trend towards digital channels continues, the Group has made a corresponding greater shift in marketing and advertising budgets from traditional marketing channels to digital and online channels, and the Group expects to benefit from this dynamic operating environment. The Group's existing strategies and a favorable operating environment will be strong drivers of new user acquisition and revenue growth throughout FY2022 and into the coming financial year.Overall Performance-- Revenue for 9M2022 was HK$681.1 million, increasing 43.9% compared to HK$473.3 million recorded in 9M2021;-- Revenue for FY2022 Q3 was HK$240.2 million, increasing 27.9% compared to the HK$187.9 million recorded for FY2021 Q3;-- Gross profit margin improved to 58.2%, representing a year-on-year increase of 8.8 percentage points from 49.4%;-- Gross profit for 9M2022 was HK$396.4 million, representing an increase of 69.5% from HK$233.8 million in the same period last year. Media Segment-- The Media segment recorded a year-on-year increase in revenue of 66.2% from HK$302.7 million in 9M2021 to HK$502.9 million in 9M2022;-- Media segment revenue in North America and major European countries rebounded strongly compared to the same period last year, with year-on-year increases of 177.7% and 69.0% respectively for 9M2022;-- Gross profit margin for the Media segment increased by 7.7 percentage points versus prior year to 63.1% for 9M2022. The improvements were mainly due to production cost efficiencies generated from increased scale of media advertising production and streamlined campaign deliveries in the Media segment. E-commerce and Retail Segment-- The E-commerce and Retail segment revenue for 9M2022 was HK$178.2 million, representing an increase of 4.4% from HK$170.7 million in 9M2021;-- Gross profit from the E-commerce and Retail segment increased by 19.2% from HK$66.2 million in 9M2021 to HK$78.9 million for 9M2022, while gross profit margin improved by 5.5 percentage points to 44.3% in 9M2022 due to increased sell-through rates and higher proportion of full-price sales achieved from continuous improvements in product marketing and streamlined consumer shopping experience;-- The Group continued its product expansion strategy, expanding its offerings to homeware, toys and other lifestyle products on HBX to cater to all aspects of the HBX customer's lifestyle needs.Operating Expenses-- Selling and marketing expenses increased by 42.9% from HK$78.2 million for 9M2021 to HK$111.8 million for 9M2022. As a percentage of revenue, selling and marketing expenses remained constant at 16.5% for 9M2021 and 9M2022;-- Administrative and operating expenses were HK$151.9 million for 9M2022, up by 77.6% from HK$85.5 million for 9M2021. As a percentage of revenue, administrative and operating expenses increased from 18.1% for 9M2021 to 22.3% for 9M2022;-- Increase in operating expenses as a percentage of revenue from 34.6% in 9M2021 to 38.7% in the current period was mainly caused by (i) increases in headcounts within the Group's sales and marketing team to facilitate current and future business growth; and (ii) prudent cost management during the COVID-19 pandemic last year and government subsidies received in the comparative period.For further details on the quarterly results performance, visit the Group's corporate website to view the full announcement.https://hypebeast.ltd/investorsInvestor Enquiries: investors@hypebeast.comMedia Inquiries: pr@hypebeast.comStrategic Financial Relations LimitedVicky Lee Tel: (852) 2864 4834 Email: vicky.lee@sprg.com.hkIvy Chan Tel: (852) 2864 4890 Email: ivy.chan@sprg.com.hkFax: (852) 2527 1196About Hypebeast Limited (Stock Code: 0150.HK) Hypebeast Ltd. is a publicly listed media and retail company that lives at the forefront of global culture, offering digital media, e-commerce and creative agency services to cultural enthusiasts worldwide . Listed on the Hong Kong Stock Exchange since 2016 and with a total reach of over 44.7M users across all platforms, the Group's Hypemedia division boasts global readership across Asia Pacific, North America, Europe and more, with the flagship Hypebeast platform available in five languages. The platform and community empowers the Group's various businesses, which encompasses Hypebeast and its multiple content distribution platforms, Hypemaker, its global creative agency and HBX, its e-commerce and retail platform. Copyright 2022 ACN Newswire. All rights reserved. (via SEAPRWire)

16 2 月, 2022

Malaysian Genomics Resource Centre Berhad Records Significant Increase in Revenue of RM7.63 Million

PETALING JAYA, MALAYSIA, Feb 16, 2022 - (ACN Newswire via SEAPRWire.com) - Malaysian Genomics Resource Centre Berhad ("MGRC" or "the Group"), a leading genomics and biopharmaceutical specialist, today announced that it recorded revenue of RM7.63 million for the second quarter ended 31 December 2021 ("2Q FY2022"), a significant increase of RM7.49 million compared with revenue of RM0.14 million for the corresponding quarter of the previous year.The increase in revenue stems from the contribution of the Group's biopharmaceuticals division, which contributed 78% of total revenue and was largely due to the distribution of immunotherapy and cell therapies as well as COVID-19 vaccine distribution and administration.MGRC registered profit after tax ("PAT") of RM1.01 million for 2Q FY2022 compared with a loss of RM1.55 million in the previous corresponding quarter, with the swing back to profitability due to the higher margins from the distribution of immunotherapy and cell therapies.For the first six months ended 31 December 2021 ("1H FY2022"), the Group registered revenue of RM16.94 million, which is an increase of RM16.72 million compared with revenue of RM0.22 million in the corresponding period of the previous financial year. MGRC registered PAT of RM1.25 million for 1H FY2022 compared to a loss of RM2.39 million in the corresponding period of the previous financial year.Dato' Alvin Nesakumar, Executive Director of MGRC, said, "The significant improvement in revenue was due to the new revenue streams arising from our diversification into the biopharmaceuticals sector in late 2020 while our return to profitability was led by the successful ramp up in distribution of higher margin immunotherapy and cell therapies. Our financial performance for the quarter under review is progressing positively and we believe it is strong enough for us to start regularising our stock listing status."The Group also announced the redesignation of Encik Noor Azri bin Dato' Sri Noor Azerai ("Azri Azerai") as an Executive Director from Independent Director previously. His redesignation takes effect from 16 February 2022. Azri Azerai is currently an Executive Director of Bintai Kinden Corporation Berhad ("Bintai Kinden"), and an Independent Non-Executive Director in both Serba Dinamik Holdings Berhad and NWP Holdings Berhad."We welcome Azri Azerai as our executive director as he shares the same vision for MGRC's future as the region's leading precision and personalised healthcare services company. He has the experience in helping the turnaround of Bintai Kinden's financial performance to black subsequent to his appointment on its Board in July 2021, following which he was redesignated as the Deputy CEO within a year."Alvin added, "As the economy continues to recover, we are seeing important opportunities for innovative commercial partnerships and collaborations in the fields of genomics and biopharmaceuticals. We look forward to announcing these new initiatives in the coming months." Copyright 2022 ACN Newswire. All rights reserved. (via SEAPRWire)

30 8 月, 2021

Alltronics Announces 2021 Interim Results

HONG KONG, Aug 30, 2021 - (ACN Newswire via SEAPRWire.com) - Alltronics Holdings Limited ("Alltronics" or the "Group") (SEHK: 833), a leading electronic products manufacturer and a provider of energy-saving business solutions, has today announced its unaudited interim results for the six months ended 30 June 2021 ("1H2021", "first half of 2021" or "the Period").During the Period, the Group's revenue increased by 19.0% to HK$860 million (1H2020: HK$722.8 million), mainly attributable to the increase in sales of electronic products. Gross profit amounted to HK$141.6 million (1H2020: HK$147.3 million) and gross profit margin was 16.5% (1H2020: 20.4%). Profit for the Period attributable to owners of the Company was HK$48.1 million, compared to a profit of HK$42.3 million for the same period in 2020. The improvement in net profit was mainly due to the reduction in impairment losses on financial assets and there was no write-off of long term receivables during the Period.Basic earnings per share were HK5.08 cents. In its appreciation for the shareholders' continuous support, the Board has declared the payment of an interim dividend of HK1.0 cent per share.Business Review and ProspectsFor the electronic products segment, total sales revenue comprises sales of finished electronic products, plastic moulds and components and other components for electronic products. Despite the continuous impact of COVID-19 pandemic on the global economy, total sales revenue from electronic products during the Period had increased by 19.3% from HK$721 million to HK$860 million. Specifically, the demand for the Group's irrigation controller products increased by approximately HK$38 million to HK$295 million, while sales of electronic component products increased by approximately HK$50 million. Sales of walkie-talkie products also increased slightly by approximately HK$4 million, whereas sales of electrostatic disinfectant sprayers remained stable at approximately HK$150 million during the Period. Although the outbreak of COVID-19 last year led to significant increase in demand for the Group's electrostatic disinfectant sprayers, the Group expected that the total sales revenue from electrostatic disinfectant sprayers for this year is unlikely to maintain at the same level. Nevertheless, the management is confident that the performance of the Group's irrigation controller products for this year will remain strong with steady growth. The demand for other electronic products will also remain stable. New products expected to be launched in the fourth quarter of the year will as well provide new momentum for growth in revenue.The operation of the biodiesel products and energy efficient gas stoves segment in Hong Kong continued to be affected by the pandemic during the Period, with total revenue of approximately HK$0.2 million. The Group expects the business of biodiesel products and energy-efficient gas stoves segment to remain stable during the second half of 2021.Regarding the energy saving business segment, total sales revenue for the Period were HK$0.2 million as the installation work at the retail stores of Suning.com Co., Ltd. ceased since last year. The Group therefore foresees the revenue will remain at similar level during the second half of 2021.Looking ahead, the Group will keep alert and remain cautious on its performance, as the uncertainties in the business environment continue, and the ongoing COVID-19 pandemic as well as trade disputes between the United States and the PRC may lead to further negative impact on the global economy. At the same time, the Group will strive to manage these factors and tighten control over production costs and overheads, and also improve production efficiency in order to maximise the gross profit margin.Mr. Lam Yin Kee, Chairman of Alltronics concluded, "The COVID-19 pandemic continued to affect the business operations of the Group and its associated companies, and we expect the difficult business environment may last for some time. With that being said, the overall performance of the Group during the first half of the year has improved when compared to prior year. We will certainly continue to explore opportunities with other potential customers for new electronic products with the aim to broaden revenue base and maintain growth momentum, as a result contributing to our shareholders and stakeholders."About Alltronics Holdings Limited (Stock code: 833)Alltronics Holdings Limited is mainly engaged in the design and manufacture of a wide range of electronic products with quality and style, supplying biodiesel products and energy efficient gas stoves, as well as the provision of energy-saving business solutions. The Company is a constituent stock of the Morgan Stanley Capital International ("MSCI") Hong Kong Micro Cap Index. For more information, please visit the company website http://www.alltronics.com.hk/.Media enquiriesStrategic Financial Relations LimitedVicky Lee Tel.: +852 2864 4834 Email : vicky.lee@sprg.com.hkAngela Wong Tel.: +852 2114 4953 Email : angela.wong@sprg.com.hkPinky Hui Tel.: +852 2114 2897 Email : pinky.hui@sprg.com.hkWebsite: www.sprg.com.hk Copyright 2021 ACN Newswire. All rights reserved. (via SEAPRWire)

16 8 月, 2021

Turnaround seen at PIL Results, showing improvement in First Half 2021 with Record Quarterly Revenue

HONG KONG, Aug 16, 2021 - (ACN Newswire via SEAPRWire.com) - Pentamaster International Limited (1665.HK) ("PIL" or "the Group") which is listed on the Main Board of The Stock Exchange of Hong Kong Limited announced its interim financial results for the six months period ended 30 June 2021 ("1H2021") today. The Group recorded a revenue of MYR245.6 million, while its net profit stood at MYR55.7 million, showing an improvement of approximately 21.0% and 5.6% respectively from the corresponding period last year.In 1H2021, the Group's revenue was contributed by both the ATE and FAS segments, with each constituting approximately 72.0% and 28.0% respectively of the Group's total revenue in the current period. The ATE segment continued to contribute the larger portion of revenue and profit to the Group's results for the first half of 2021 at a revenue contribution rate of 72.0%. This segment recorded an increase in revenue of MYR39.2 million, representing a growth of 28.3%, to MYR177.6 million in 1H2021 as compared to the corresponding period in 2020. Given the continued recovery in the smartphone market with 5G capability and other incremental features, the electro-optical segment of the Group's business segment contributed MYR138.2 million in revenue for the 1H2021, representing a 53.8% growth as compared to 1H2020. The ATE segment also benefitted from the semiconductor industry where revenue from this business segment shown a growth of 37.7% as compared to 1H2020. Given the global automotive industry's production is wilting under pressure from the supply chain challenges since beginning of the year, the Group's revenue from the automotive segment witnessed an overall drop of 7.2% in 1H2021 as compared to 1H2020. However, the Group expects the revenue contribution from the automotive segment to rebound in the second half of the year given the momentum of the Group's current order book and as the production of the global automotive industry normalise. Overall, barring any major deterioration of the COVID-19 pandemic situation, the Group continues to witness structural growth within its electro-optical and automotive segments.In 1H2021, revenue from the FAS segment increased by approximately 5.4% to MYR70.8 million as compared to MYR67.1 million recorded in the corresponding period last year. The FAS segment has continued to chalk growth in 1H2021 with the increasing demand for the Group's i-ARMS (intelligent Automated Robotic Manufacturing System) albeit at a lower growth tangent as project's complexity undertaken by FAS segment requires a longer project lead time for revenue recognition. The FAS segment was predominantly contributed by the consumer and industrial products segment as well as the medical devices segment, where deployment of the Group's proprietary i-ARMS was more prevalent within these segments. Meanwhile, the COVID-19 pandemic may increase the adoption and transition towards automation as concerns regarding social distancing and spread of the virus has forced manufacturing companies and businesses worldwide towards digital technologies. Against the backdrop of this automation trends, the Group will leverage on its competitive advantages to further broaden the capability of its automation manufacturing solutions and continue to grow its FAS segment.OutlookAs 2021 remains an observance year with the ongoing threat of the pandemic, the Group has been confronting all sorts of uncertainties and volatilities in the form of supply chain constraint and disruptive logistics arrangement. Amid the challenges, the Group continuously put in place the necessary safety measures, operating procedures and system infrastructure to embrace the volatilities and uncertainties in an orderly sustainable manner to minimise disruption to its business operation. As the roll-out of vaccination is gathering pace globally and in Malaysia, the Group anticipates a more stable and favourable operating environment for its timely delivery commitment of projects on hand. Despite having to endure the severe social and economic challenges presented by the pandemic, the situation is not all doom and gloom. Through the pandemic, the Group witnessed the emergence of new ways of working in a business environment where there is an accelerated pace towards the greater adoption of digital transformation in our daily lives. Within this context and in an encouraging development, the Group saw the order intake momentum gathering pace since the beginning of the year and such momentum continues to prevail as it enters the second half of the year on the back of several catalysts driving both its ATE and FAS segment. At present, with the growing adoption of digital technologies, which encompasses AI, cloud computing, big data and the Internet of Things ("IoT") which further compounded by the deepening application of 5G, optical sensing and electrification in the automotive industry, the Group is exposed to the rapid development of technological revolution and industrial transformation which enable the Group to seize the opportunities. In general, the Group expects the demand level in its major markets in particular the electrooptical and automotive industry to improve. With the prevalence of optoelectronics and 3D sensing technology, further compounded by the pandemic situation, the Group's core products and solutions that cater for a wide range of smart sensors will become increasingly important to its customers. Additionally, demand from the automotive market is expected to continue to be strong for the Group following the increasing wave of development of automotive electrification and various technology advancements changing the automotive landscape. Given the Group's current exposure and product portfolio in the automotive industry encompassing a diverse area of the automotive test solution from front-end to back-end, the Group will be able to play a dominant role in this ecosystem. In respect of the Group's exposure in the medical segment, the Group is making progress in the prototyping stage of single-use medical devices which involves the intravenous catheters and pen needle and the timeline for ISO13485 certification by 2021 remains on track. In view of the perceptible momentum from local companies in China to localise their production amid the rising geopolitical tensions, coupled with China's ambition to leapfrog to the upper echelons of technology and its initiative to funnel investment into integrated power module market, the Group's recent establishment of a wholly foreign-owned enterprise in China, namely Pentamaster Technology (Jiangsu) Limited ("PT Jiangsu") serves part of the Group's Greater China expansion plans. The Group will leverage on its core competency and competitive advantage specifically in the electro-optical, automotive and medical segment to further capitalise on the demand for its customised test equipment in the region. Consequently, through PT Jiangsu, the Group hopes to reinforce its position in China and paves its way for more strategic opportunity. While macroeconomic uncertainties may linger, the Group will continue to focus on its business fundamentals and capitalise on its financial wherewithal to strengthen its product portfolio and position in the industry. Barring any drastic deterioration of the current market conditions, the Group anticipates a better performance in 2021 and specifically, the Group expects its revenue to set another new record for the year. On top of the Group's focus on growing revenue, the Group strongly believes in attaining a sustainable business operation in terms of its profitability and prospect and such policy remains a top priority of the Group. On a longer term basis, the Group looks forward to deepening and diversifying its presence in high-growth industry such as automotive, IoT, industrial electronics, optoelectronics and medical where the Group stands to benefit with its breadth of equipment and solution offerings.About Pentamaster International LimitedPIL (HKEX stock code: 1665) is a leading global supplier in providing automation technology and solutions to multinational manufacturers mainly in the semiconductor, automotive, electrical & electronics, medical devices and consumer industrial products sectors spanning APAC, North America and Europe. The Group's broad range of integrated automation products and solutions entails innovating, designing, manufacturing and installing automated equipment and/or automated manufacturing solutions. To learn more about PIL, please visit us at www.pentamaster.com.myFor media enquiries, please contact:Pentamaster International LimitedEmail: investor.relation@pentamaster.com.my ICA Investor Relations (Asia) LimitedE-mail: pentamaster@icaasia.com Copyright 2021 ACN Newswire. All rights reserved. (via SEAPRWire)